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Lack of valid and reliable pain assessment in the neonatal population has become a significant 
challenge in the Neonatal Intensive Care Unit (NICU). Current practice in the NICU involves the 
meticulous, time-consuming and potentially bias process of manual interpretation of pain scores. 
In an attempt to forego the manual scoring system, this thesis presents an initial framework to 
automate a partial pain score for newborn infants using big data analytics that automates the 
analysis of high speed physiological data. The design of the novel Artemis Premature Infant Pain 
Profile (APIPP) is proposed in this thesis. An ethically approved retrospective clinical research 
study was performed to calculate APIPP scores from premature infant data collected from the 
Artemis platform. Using the Premature Infant Pain Profile (PIPP) as the base gold standard scale, 
scoring techniques were automated to create data abstractions from the physiological streams of 
Heart Rate (HR) and Oxygen Saturation (SpO2). These were then brought together to compute an 
automated partial pain score (APIPP) that was based on gestational age, HR and SpO2. Through 
the retrospective clinical research study, and to evaluate the effectiveness and feasibility of 
automating the scale in the future, APIPP was retrospectively compared with the PIPP which 
was manually scored by nursing staff at The Hospital for Sick Children, Toronto. Furthermore, 
the characteristics in HR were also assessed in a thorough manner by preforming statistical tests 
to assess the resourcefulness of HR as a measure to identify a pain response. Future research will 
focus on the clinical validation of this work by carrying out prospective research to implement an 
algorithm based on the design proposed in this thesis that can be integrated into a clinical 
decision support system named Artemis.  
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“Every worthwhile accomplishment, big or little, has its stages of drudgery and triumph: a 
beginning, a struggle, and a victory”	– Mahatma Gandhi	
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Chapter 1 - Introduction 
This thesis presents an initial framework to automate a pain score for newborn infants using big 
data analytics. This research will also present an approach to integrate and use physiological 
variables to identify pain in an objective manner. Management of pain in the neonatal population 
is one of the most challenging problems in the Neonatal Intensive Care Unit (NICU).  This 
research is motivated by a lack of adequate, validated pain assessment tools to assess neonatal pain. 
There is also a significant need for validated Clinical Decision Support Systems (CDSS) that can 
provide automated generation of pain scores in the neonatal population. In this thesis, an attempt will 
be made to design a CDSS for the automated real-time creation of a partial Premature Infant Pain 
Profile (PIPP) score. The elements of the PIPP score used in this design will be those that can be 
calculated without the need for a visual assessment of the patient at the bedside. Many gaps exist 
in the knowledge relating to the optimal utilization and accessibility of techniques that assess 
pain in a valid and reliable manner. The field of informatics has great potential for designing 
physiological based scales for the neonatal population, where such scales can utilize CDSS for 
the continuous assessment of pain.   
1.1 Pain in Neonatal Population 
Pain management in the neonatal population is a significant challenge within the health care 
community. During their stay at the Neonatal Intensive Care Unit (NICU), preterm infants are 
exposed to a high number of painful procedures. Specifically, infants undergo a range of 2 to 14 
invasive procedures each day, for which less than one-third receive an analgesic therapy 
(Ranger, Johnston, & Anand, 2007). The most common procedures, heel lance or venipuncture, 
are used to obtain blood for screening and medical monitoring. These particular procedures are 
painful for infants, where such noxious stimulation can cause changes in brain activity that is 
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similar to that of adults (Harrison et al., 2015). The International Association for the Study of 
Pain defines pain as “an unpleasant sensory and emotional experience associated with actual or 
potential tissue damage or described in terms of such damage” ("Prevention and management of 
pain and stress in the neonate. ," 2000) Another definition of pain that is widely used or 
understood within the health care community states that “pain is whatever the experiencing 
person says it is, existing whenever he/she says it does” (Worley, Fabrizi, Boyd, & Slater, 2012). 
Until the 1990s, newborns in some clinical centers were undergoing surgery with minimal 
anaesthesia due to the common assumption that neonates could not perceive pain early in life. 
Despite the pain associated with certain surgical procedures, such as lumbar punctures or 
circumcisions, newborns received little or no pain management postoperatively (Slater, 
Cantarella, Franck, Meek, & Fitzgerald, 2008). 
Since then, clinicians have become more aware of the fact that pain may be experienced 
from the earliest stages of postnatal life (Slater et al., 2008).  Additional clinical evidence has 
shown further support, indicating that exposure to prolonged and repetitive pain-related stress in 
infants born very preterm can have potential long-term effects that can lead to altered 
neurobehavioral development in vulnerable infants (Anand, Palmer, & Papanicolaou, 2013; 
Brummelte et al., 2012; Doesburg et al., 2013; Grunau, 2013). For example, specific brain 
connections form during early stages of development, where such connections play a role in 
experiencing pain during this early stage of life. In one study, Lowery provides details regarding 
early brain development. He states that connections to the thalamus begin at 14 gestational 
weeks and are completed by 20 gestational weeks. Additionally, thalamocortical connections are 
present from 13 gestational weeks and undergo further development until 26 to 30 gestational 
weeks (Lowery et al., 2007). Additional extensive research has shown that neurons of the 
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cerebral cortex begin a migration from the periventricular zone at 8 weeks of gestation. At 20 
gestational weeks, the cortex has acquired a full complement of neurons with glial perforation 
active throughout childhood (Lowery et al., 2007). Synaptic formation begins at 12 gestational 
weeks, accelerates rapidly during the last trimester of pregnancy, and peaks during the first year 
of life (Stiles & Jernigan, 2010). Electroencephalographic activity appears for the first time at 20 
weeks of gestation, becomes synchronized at 26 weeks of gestation, and shows sleep/wake 
cycling at 30 weeks of gestation (Lowery et al., 2007). Due to such rapid changes in brain 
structure, there is growing concern that repeated pain in vulnerable neonates may result in 
various long-term consequences, including emotional, behavioural and learning disabilities 
(Anand & Scalzo, 2000; Bhutta & Anand, 2002; "Prevention and Management of Pain in the 
Neonate: An Update," 2006). These findings confirm that premature infants are able to indeed 
experience pain. Additional evidence involving animal models and humans reveal that early pain 
experiences can alter subsequent central nervous system (CNS) function (Fitzgerald, 2005). 
Despite these revelations, a substantial challenge remains with precisely quantifying the amount 
of pain that premature infants experience. By having the ability to communicate the severity of 
pain in a clinical setting, individuals are able to seek strategies to ease the pain by using 
analgesics or alternative interventions. However, the inability to effectively communicate one’s 
distress of pain causes individuals, specifically premature infants, to be vulnerable to prolonged 
suffering.  
Pain that is ignored and not treated can have immediate and long-term effects due to 
structural and physiological changes within the nervous system (Slater et al., 2008). For 
example, the body tends to respond to untreated pain by increasing the release of stress 
hormones. If the pain is left untreated, such a change can result in increased morbidity and 
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mortality (Slater et al., 2008). Studies have also shown that improper pain management, or 
unnoticed and untreated pain from an early age could potentially lead to long-term effects due to 
the developmental plasticity of the immature brain (Grunau, 2013). These effects may include 
altered pain perception, chronic pain syndromes, and somatic complaints such as sleep 
disturbances, feeding problems, and inability to self-regulate in response to internal and external 
stressors (Slater et al., 2008). A study performed by Anand et al. with neonatal rats also found 
that exposure to repetitive neonatal pain can result in decreased pain thresholds (Anand, Coskun, 
Thrivikraman, Nemeroff, & Plotsky, 1999). Furthermore, attention deficit disorders, learning 
disorders, and behavioural problems in later childhood may be linked to repetitive pain in the 
preterm infant (Slater et al., 2008). Due to such serious outcomes, the application of optimal 
tools and specific techniques for quantifying pain becomes vital in a vulnerable population like 
that of premature infants.  
1.2 Pain Detection Tools 
Initially, pain detection tools were designed for use in research settings and were univariate in 
their approach. These tools highly focused on behavioural changes such as crying and body 
movements. Multiple factors limit or prevent the demonstration of such behavioural changes in 
premature infants. For this reason, certain bio-physiological assessment clues were added to 
current behavioural tools in an effort to improve sensitivity. However, the incorporation of these 
bio-physiological clues in current scales has remained minimal. Since the 1980s, a variety of 
physiologic parameters have served to estimate pain intensity of acute painful procedures (Van 
Dijk & Tibboel, 2012). Even though more than 40 pain assessment tools are available, no single 
instrument has demonstrated superiority over the others for use in this vulnerable population 
(Ranger et al., 2007). Heart rate and blood pressure are often included in multidimensional 
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scales. Some scales involve the comparison of heart rate and blood pressure against their 
baseline value. For instance, an increase of more than 20% from baseline (N-PASS scale) or a 
decrease of heart rate of 10 beats per minute (MAPS) is used as an indication of pain (Van Dijk 
& Tibboel, 2012). Automated analysis of the various physiological changes described in Chapter 
2 proves that validated automated systems can be created for measuring pain in the neonatal 
population. 
The automatic analysis of pain has received greater attention over the last few years due 
to the growth in health informatics. Many research studies have outlined the need for better pain 
assessment tools (Gibbins & Stevens, 2001; Korhonen, Haho, & Polkki, 2013; "Prevention and 
Management of Pain in the Neonate: An Update," 2006; Slater et al., 2008; Van Dijk & Tibboel, 
2012). Studies have shown that periodic monitoring of patient pain levels by physicians and 
nurses can lead to large improvements (Rudovic, Pavlovic, & Pantic, 2013).  However, 
healthcare providers experience an increased burden of work and stress; thus such pain 
monitoring becomes difficult to sustain. For this reason, an automated system would be an ideal 
solution. To date, there has been very limited health information technology research in the 
neonatal population, which then presents a good opportunity for innovation. A recent study 
verified the advantages of objective pain assessment methods over the currently used subjective 
pain rating tools (Tejman-Yarden et al., 2016). Although there is vast potential for the use of 
computer systems for pain assessment in the neonatal population, there are very few studies in 
the computer systems literature addressing this particular issue. As such, there is a need for 
computerized tools to support pain management in neonates. However, there is a lack of 
empirical studies that provide guidance on how to design such tools. Another major drawback is 
the fact that most of the studies have been implemented in the adult population. Thus, 
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implementing specific concepts from these adult studies in the neonatal population is highly 
valuable.   
1.3 Information Systems 
Introducing information systems into healthcare has proven to be a challenge due to the 
complexities of both technology and healthcare. The neonatal space is particularly susceptible to 
information systems failure given that neonates are a very sensitive population, where each 
patient is individually different. In order for information systems to succeed in such a vulnerable 
population, the interconnection of the medical, technical and social contexts of healthcare within 
the design of these systems is highly important. Effective design starts with a solid conceptual 
model. The concept for these computer-based systems should be interdisciplinary and should be 
conceived by physicians as well as other involved healthcare practitioners to enhance the 
assessment, diagnosis and management of severe pain in such a vulnerable population. 
Even though verbal methods (i.e., pain scales, questionnaires) and visual analogue scales 
are commonly used for measuring clinical pain, such tools tend to lack in reliability or validity 
when applied to non-verbal patients (Herr, Bjoro, & Decker, 2006). Numerous experimental 
studies have been conducted in such patients; however, the systems described in such studies 
have not been validated for use in all clinical settings. Some behavioural tools that measure facial 
expressions, vocalizations and body movements also exist; however, such tools may also not be 
entirely accurate as neonates are at times highly sedated or severely premature to provide any 
behavioural distress cues. Therefore, there is a need to develop a pain assessment tool that is 
based on physiology, and requires no communication on the part of patient. Researchers have 
long sought to develop a physiology-based pain assessment that does not depend on patient 
volitional behaviours. However, minimal advances have been performed in this area. While 
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several physiological variables have shown statistically significant correlations with the presence 
of pain or with pain intensity, no measure has provided a sufficiently high relationship with pain 
to be used as a valid surrogate for self-reports. Therefore, despite many years of research, there is 
currently no accepted technique for the physiologic assessment of pain in neonates. 
1.4 Research Motivations 
The challenge has been to bridge the gap between research and clinical practice by devising a 
pain assessment method for premature infants that is suitable in all circumstances and conditions. 
Despite the fact that the scientific community has disregarded misconceptions relating to pain in 
the neonatal population, there remains a lack of a ‘gold standard’ to measure pain precisely. 
Current pain measurement scales that are used in the NICU are highly based on behavioural 
indicators. The most commonly used scales are listed in Table 1. Behavioural indicators, such as 
facial expression, movement, and brow bulge, tend to be inadequate as the premature infants are 
heavily sedated or are not able to move due to the immaturity of their nervous system. 
Behavioural measurements are widely used for infants and nonverbal subjects of all ages (Berde 
& McGrath, 2009). Such measurements are sensitive to fear, anxiety as well as pain, resulting in 
an underestimation of pain intensity as compared to self-report measures in patients with 
persistent pain (Berde & McGrath, 2009). Also, some infants have limited ability to behaviorally 
express pain due to specific disorders, underdevelopment as a result of prematurity as well as 
physical exertion (Evans, McCartney, Lawhon, & Galloway, 2005). Assessing such behavioural 
indicators pose challenges for clinical practice and research due to subjectivity; as such, these 
indicators can be perceived differently by each health care professional. Additionally, as Table 1 
presents, most pain scales do not adjust for gestational age when scoring. Because neonates tend 
to react differently to pain at varying gestational ages, accounting for the gestational age is 
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important, otherwise inaccuracy and misinterpretation can occur. In a study done by Johnston 
and Stevens, the authors compared the responses of newly-born infants at 32-week gestation with 
those who were currently 32-week gestational age (infants born 4 weeks earlier at 28-week 
gestation). When compared to the newly born 32-week gestation infant responses to heel sticks, 
the earlier born (28-week gestation) infants had significantly greater heart rate, significantly 
lower oxygen saturation, and fewer upper facial expressions of pain (Johnston & Stevens, 1996). 
These changes can categorically alter pain scores. For this reason, designing a pain scoring 

















Heart rate & 
oxygen saturation 
Brow bulge, eye 
squeeze, nasolabial 
furrow 
28-40 week Yes 













cry, movement of 
arms and legs, state 
arousal 






















None Facial muscle 
group movement 
Preterm and term 
neonates, infants at 4 




The fundamental limitations in pain assessment for neonates stem from subjective assessment 
criteria, rather than quantifiable and measurable data, resulting in poor quality and inconsistent 
treatment of patient pain management. Pain is commonly known to be a subjective experience 
for which the gold standard of measurement is self-report (Brown, Chatterjee, Younger, & 
Mackey, 2011). Even though self-reported pain is clinically useful and proves to be an effective 
assessment approach in most situations, self-reported pain can fail for certain vulnerable 
populations such as neonates. Pain is an individual sensation that is difficult to interpret without 
any communication from the patient. Neonates, for example, are not able to provide self-reports 
of pain. Thus, the use of objective measures of pain assessment is imperative.  
Health care professionals can also be strongly biased towards assessing these behavioural 
changes, resulting in inaccuracy. By using objective signs of subjective change, accuracy of pain 
assessments can significantly improve; however, these signs are not currently used in a precise 
manner. Patients would benefit from pain assessments that are performed as frequent as heart 
rate, temperature, respiratory rate, and blood pressure measurements. Evidently, we can use these 
objective physiological indicators to carefully quantify abnormalities or pain in premature infants 
with addition of contextual impression of the neonate as assessed by nurses.  
It is difficult to implement guidelines for such a complex problem. Pain assessment 
guidelines today describe the preferred pain assessment tool and criteria with respect to the 
frequency of scoring (Van Dijk & Tibboel, 2012). However, the availability of such guidelines 
does not necessarily translate into proper usage by the hospital staff. A survey done among 272 
paediatric nurses elicited potential barriers to optimal pain management (Czarnecki et al., 2011). 
Some of these included insufficient physician orders, insufficient time to pre-medicate patients 
before procedures and low priority given to pain management by physicians (Van Dijk & 
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Tibboel, 2012). This thesis proposes that by greater use of physiological indicators and more 
frequent assessment through automated pain assessment tools, these gaps can be eliminated. 
Currently, there is insufficient research relating to using physiological indicators to measure pain 
and its validity. In the future, there is scope for using this thesis work to create rule based-
automated systems for physiological indicators, which can potentially remove many of the 
above-mentioned hurdles.    
1.5 Research Aims and Objectives 
The primary aim of this research is to design an initial framework to automate a partial pain 
score for newborn infants using big data analytics that automates the analysis of high speed 
physiological data. This study will also assess characteristics in heart rate to explore the 
resourcefulness of heart rate as a measure to assess pain in newborn infants. The objective is to 
use physiological data for creating an alternate way to generate a score, that is currently 
generated manually.  
1.6 Research Questions 
1) Can a scoring system be designed using real-time big data analytics to quantify pain in 
the neonatal population? 
2) Can a real-time algorithm be designed using the knowledge presented in this thesis? 
3) Is more frequent monitoring of pain possible by creating an automated system by using 
the Artemis platform? 
1.7 Research Hypothesis  
This research study will critically examine the following three hypotheses: 
1) A scoring system can be designed for the elements of the score that do not require visual 
observation at bedside using real-time big data analytic techniques to quantify pain in the 
neonatal population. 
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2) A real-time algorithm can be designed using the knowledge presented in this thesis.  
3) More frequent monitoring of pain is possible by creating an automated system by using 
the Artemis platform.  
1.8 Thesis Structure 
The thesis is structured as follows: Chapter 1 introduced the vital themes of this thesis including 
an overview on pain in the neonatal population, and the tools used to measure pain with the use 
of information systems. Chapter 1 also presented the research motivations as well as the research 
questions and hypothesis. Chapter 2 consists of the literature review, which outlines the 
background on the variety of machine learning/automated systems used in the past as well as a 
review on using physiological variables as indicators of pain. Chapter 3 presents a detailed 
description of the Artemis platform and how this research will use this platform to create a 
partial PIPP score. Chapter 4 presents two phases of the methodology: the data preparation phase 
and the data model phase. Chapter 5 displays in detail how the data model can be run to create an 
automated partial PIPP score using Artemis. Chapter 6 explores the physiological and clinical 
side of pain and outlines in detail the usefulness of heart rate as a physiological marker for the 
measurement of pain by presenting various experiments conducted with retrospective data. 
Chapter 7 will provide a discussion relating to the experiments completed. Finally, Chapter 8 
concludes the thesis with identifying limitations of this research work as well as outlining areas 




Chapter 2 - Literature Review 
This literature review chapter discusses the various studies conducted in the area of pain 
management to measure pain. The literature review begins with a discussion on how health 
information systems can be used to assess pain. Following is a review on how physiological 
parameters have been used to measure pain. It was important to review previous studies that 
were conducted using physiological changes to assess pain in order to create a new scale that 
provides more frequent monitoring. Lastly, a review was conducted on various 
computerized/automated pain measurement systems that have been validated till date to better 
understand the need for these systems to evaluate pain in the neonatal population. 
2.1 Pain and Health Information Systems  
Information is the critical resource around which health care organizations are designed. The 
utility of these information resources is what is of importance to alter the way pain is assessed. It 
is unfortunate that despite having an array of information resources within health care 
organizations, patient pain information continues to be documented in an analog format using 
paper and pen. It is important that we invest in and develop computerized automated systems for 
patient care. If this is implemented, the system can work as a safeguard for not only health care 
professionals but also patients. Furthermore, today’s governments and health care organizations 
also have a strong need for automatic tools such as clinical decision support systems which can 
combine advances in information technology (IT) systems to help reduce the health service costs 
caused by patient safety incidents (Kong et al., 2012). 
Computer-based automated systems or information tools are specific information 
technology (IT) applications that supports the needs of different types of clinicians and health 
care professionals. Introducing such applications and decision support systems into a health care 
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setting can enhance clinical tasks by providing access to information and communication 
technologies. It is important to turn to informatics-based solutions as healthcare is looking for 
new and innovative ways to deliver more services with fewer resources. However, the means by 
which information systems are both designed and implemented will impact how successful the 
system will be at enhancing care delivery. A key component to successful information system 
design is the methodological accuracy by which design requirements are collected and applied. 
Developing computer based automated systems and informatics tools has been a 
challenge because despite a number of different systems design approaches, many health care IT 
projects end up being problematic after implementation (Kuziemsky, Weber-Jahnke, Lau, & 
Downing, 2008). To avoid this in the neonatal population, it is important to analyze the needs of 
these systems and to use an interdisciplinary approach to design the system to avoid failure. 
Currently, very few health information systems are used in the neonatal pain domain. Many 
health care organizations are still continuing to use paper based scales to measure pain in the 
premature infant. Additionally, The Hospital for Sick Children, which is the clinical institution 
used in this study, uses the Premature Infant Pain Profile (PIPP), a paper based scale to quantify 
pain. Hence, there is vast potential in automating pain scales in the neonatal population through 
big data analytics in real-time.  
Since neonatal care tends to be very fragile, it is particularly important that the needs of 
these vulnerable patients and in many cases their families are represented in the new information 
systems that are applied to this domain. Furthermore, it is important to also ensure that these 
systems provide utility for its users such as physicians and nurses. Therefore, information system 
designed to enhance neonatal care requires understanding of multiple practices and settings to 
avoid failure or inaccuracy. 
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Neonatal pain management should involve a team or holistic based approach involving 
physicians, nurses and counsellors to ensure the system design is applicable to all areas. It is also 
important to consider that in healthcare, the users may not only be the health care professionals 
using the system but also the patients and family members whose care is being managed. Since 
neonatal care tends to be very sensitive, it is particularly important that the needs of these 
vulnerable patients and in many cases their families are represented in the new information 
systems that are applied to this domain.  
Pain is an important indicator of medical conditions and disease processes.  Health 
professionals are responsible for diagnosing pain, determining when pain management is 
necessary, and developing treatment plans. To accomplish these tasks, health professionals 
employ a variety of assessment tools for evaluating patient self-reports. In the case of preverbal 
children, methods have been devised to help them communicate their pain experiences. These 
children can indicate their pain levels, for example, by pointing to drawings of faces that express 
increasing levels of discomfort. Neonatal pain assessment, in contrast, depends exclusively on 
the judgment of other health care professionals. A growing body of evidence suggests that failing 
to diagnose and alleviate pain in newborns can have devastating and long-term effects (Brahnam, 
Nanni, & Sexton, 2007). A 2003 study listed several effects including immediate effects like 
irritability, fear, and sleep disturbances, short term effects such as diminished immune system, 
and long term effects like ongoing memory of the pain and also developmental delays (Mathew 
& Mathew, 2003). Multiple studies have shown that neonates who are given adequate pain relief 
consistently tend to exhibit better health outcomes. 
The majority of pain assessment instruments developed for newborns incorporate 
observations of facial activity. Even though facial activity is easier to decipher then physiological 
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measures and other behavioural indicators such as crying, instruments that have relied on facial 
information have proven unsatisfactory primarily because of problems with observer bias. One 
way to reduce bias is to incorporate evaluations that have not been made by an observer. Several 
researchers have begun investigating machine assessment of common pain indicators. Lindh et 
al. for instance, have reported some success detecting pain as it relates to heart rate variability, 
and Petroni et al. have trained neural networks to discriminate differences in neonatal cries, 
including a cry in response to pain (Lindh, Wiklund, & Hakansson, 1999; Petroni, Malowany, 
Johnston, & Stevens, 1995). Various different health informatics tools such as these will be 
discussed in section 2.3 of this literature review chapter. 
2.2 Physiological Variables as Indicators to Measure Pain 
It is vital for researchers to bring about a change in the practices of detecting pain in neonates. 
Since the scales in place currently are not fully equipped to provide most accurate results, it is 
important to redesign the approach. One of the ways to do this will be by using the constantly 
changing physiological variables. To understand a neonate’s body condition and to discover 
medical problems, caregivers continuously monitor physiological parameters such as heart rate 
(HR), respiratory rate (RR), blood oxygen saturation (SpO2), and the blood pressure. The most 
used physiological parameter in the domain of neonatal pain is that of heart rate. Various studies 
have been conducted to prove the usefulness of this measure. Changes in heart rate are widely 
used as markers of reactivity to a painful event in preterm and term infants. Characteristic 
increases in heart rate following a painful event can be readily identified because heart rate data 
is easy and relatively inexpensive to acquire. For this reason, heart rate signal is often considered 
a useful measure of pain reactivity in clinical settings where distress signals are frequently 
nonspecific and ambiguous. Even the most premature infants have the capacity to increase their 
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heart rate in response to a painful or distressing event, which reflects generalized central nervous 
system (CNS) arousal and in particular sympathetic nervous system activation (Oberlander & 
Saul, 2002). Systems that tend to control cardiovascular functions are closely linked to 
mechanisms that modulate pain reactivity, thereby, making heart rate responses a potentially 
useful physiological index of reactivity to noxious events in infants (Oberlander & Saul, 2002). 
In one particular research study, the heart rate variability (HRV) was investigated for a group of 
infants (age >34 gestational weeks) with chronic pain (Faye et al., 2010). The results showed that 
chronic pain is associated with an increase in HR, decrease in RR, and significant decrease in 
HRV.  
It is important to also examine the role of the homeostatic physiological systems that play 
a role in the mechanism of pain. For the cardiovascular system, this represents a continuous 
feedback system between the CNS, the autonomic nervous system, and peripheral components. 
These then maintain mean values of blood pressure and central venous volume within a narrow 
range, reflected in vascular tone and heart rate (Oberlander & Saul, 2002). Like all homeostatic 
functions, the greater increases and decreases of heart rate are thought to represent healthier 
individuals. The greater the organized patterns of rhythmic physiologic signals such as heart rate, 
the greater the capacity of the individual may have to respond to changing environmental 
demands (Oberlander & Saul, 2002).  
Premature infants have significant difficulties with changing environments, which is why 
they are admitted to the Neonatal Intensive Care Unit (NICU), where the environment is suitable 
for their optimal growth and health. Heart rate is a common expression of multiple physiologic 
processes that reflect CNS function, autonomic control mechanisms, metabolic activity, thoracic 
hemodynamics, and cardiac chemoreceptors and baroreceptors, as well as levels of arousal and 
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levels of activity (Oberlander & Saul, 2002). In this sense, the heart rate signal can be used as a 
parameter that links physiologic capacities with psychological functions, providing a means to 
investigate stress reactivity, clinical risk, and developmental processes during childhood 
(Oberlander & Saul, 2002). In infants, resting mean heart rate is typically between 120 and 160 
beats per minute (bpm). Heart rate is rarely constant, and its variability reflects continuous 
activity and interactions between a variety of central and peripheral control systems (Oberlander 
& Saul, 2002). Heart rate is considered an objective and easily quantifiable measure; however, 
its specificity as a measure of pain reactivity in premature infants has not been investigated in 
great detail. Overall, mainly research has found increases in mean heart rate following a noxious 
event, smaller heart rate changes observed in the presence of analgesics, and differences in 
responses between painful and non-painful conditions. These claims can help to support the use 
of heart rate as a physiologic index of pain for future in-depth studies on pain responses in the 
premature infant population. 
The systems modulating the perception of pain are coupled closely with the 
cardiovascular system. Therefore, the most common physiological pain responses usually 
include those that are coupled with the stress response. These responses include increases in 
heart rate, respiratory rate, blood pressure, intracranial pressure, palmar sweating; and decreases 
in vagal tone, heart rate variability, oxygen saturation, carbon dioxide levels, and peripheral 
blood flow (Gibbins & Stevens, 2001).  
Neonates usually tend to show increase in heart rate and decrease in heart rate variability 
(HRV) when exposed to a pain stimulus. HRV refers to the beat-to beat alterations in heart rate. 
During a study done on heel lancing, it was shown that the heart rate increased and the total 
HRV and the spectral power of the low frequency band decreased in preterm infants during heel 
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lancing and squeezing of the heel (Lindh, Wiklund, Sandman, & Hakansson, 1997). The 
frequency domain analysis of the HRV also discriminated a non-painful provocation of the 
flexor response from the noxious heel lancing and squeezing. Thus, analysis of HRV may offer a 
possibility of grading the level of distress caused by pain (Lindh et al., 1999). This can prove to 
be a useful tool in determining the intensity of pain from mild to severe. The HRV study done by 
(Faye et al., 2010) also showed that High Frequency Variability Index (HFVI) was able to 
predict the pain with sensitivity of 90% and a specificity of 75%. The background research by 
Stevens and Johnston in 1994 (Stevens & Johnston, 1994) also showed that the heel prick was 
able to give rise to an increased heart rate and decreased oxygen saturation in preterm infants.  
Besides heel lances, another routine procedure for this population is that of 
immunizations. Johnston and Strada in 1986 stated that they noticed an initial drop in heart rate 
followed by a sharp increase during routine immunizations(Johnston & Strada, 1986). In adults 
usually when they experience intense stimuli, which they perceive as danger, it provokes a 
defense response with an accelerative heart rate reaction because of sympathetic activation. 
Infants on the other hand, react to sudden noise or painful stimuli with fear paralysis reflex, 
which can be characterized by temporary sympathetic inhibition and bradycardia (Padhye, 
Williams, Khattak, & Lasky, 2009). Thus, in infants, pain and stress can cause severe problems. 
The physiological changes associated with repeated painful procedures in new born infants 
should encourage clinicians to reduce the number of stressful events during the neonatal 
intensive care. 
Heart rate variability as mentioned earlier is an important method that can provide insight 
into the interplay between sympathetic and parasympathetic activity. The high frequency band 
reflects respiratory-related activity almost entirely mediated by vagal tone (Marek, 1996). The 
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low frequency component is in some studies considered to reflect both sympathetic and 
parasympathetic activity and in others exclusively sympathetic modulation (Marek, 1996). In the 
study performed by Lindh in 1999, they recruited 25 term newborn infants on the maternity ward 
(Lindh et al., 1999). When they compared baseline levels, it was found that heel lancing 
triggered an increased total heart rate variability and power in the low frequency band, in 
contrast to the decrease during squeezing sequences (Lindh et al., 1999). 
Blood pressure is one of the vital signals used to detect a wide range of abnormalities.  
Even though, in typical measurements of the blood pressure, many clinical processes are limited 
to measurement of only systolic and diastolic pressures—as opposed to the entire signal. 
However, when the entire blood pressure signal is collected, much more information can be 
extracted from the data (Najarian & Splinter, 2012).  The analysis of the signal is done in six 
frequencies; they are then calculated and analyzed. These frequencies are the pulse rate 
(harmonics). These frequencies are ideal because most of the energy of the blood pressure signal 
is contained in these harmonics. Thus, the relative strength or weakness of these harmonics is 
often associated with certain abnormalities, which in this case can be pain (Najarian & Splinter, 
2012).  Increase in heart rate in preterm and term infants undergoing circumcision appears with a 
marked increase in blood pressure as well; which reflects increased sympathetic arousal 
(Oberlander & Saul, 2002). Diseases that are not directly related to the heart are also detected or 
diagnosed at least partially using the blood pressure signal (Najarian & Splinter, 2012). 
Analgesics also play an important role as confounding factors in measuring the above-
mentioned physiological indicators.   The confounding effects of opioid analgesics may also 
influence the heart rate or heart rate variability response to a painful stimulus. In preterm and 
term infants, opioids clearly reduce heart rate responses to noxious events. In neonates 
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undergoing surgery, opioids result in decreased cardiovascular responses to surgical stress 
(Oberlander & Saul, 2002). Studies have shown that analgesics administered to term infants, 
decreased physiologic disturbances (increased heart rate, blood pressure, and intracranial 
pressure) and improved overall clinical outcomes including decreased incidences of sepsis 
(infection), metabolic acidosis, hyperglycaemia, and clotting (Gibbins & Stevens, 2001).  
Preterm infants who did not receive analgesia for noxious stimuli had significantly more 
physiologic responses and were more likely to develop intracranial haemorrhages or other 
complications in comparison to infants who did receive analgesia (Gibbins & Stevens, 2001). 
2.3 Computerized Tools to Measure Pain 
The development of new information based computerized systems and clinical parameter 
prediction tools in the recent past have opened up a new outlook to many areas in healthcare.  
Through time, the historical development of automated machine learning algorithms and its 
applications for medical diagnosis has led to advanced and sophisticated data analysis today. 
Machine learning is a subfield of artificial intelligence. Artificial intelligence is a part of 
computer science that tries to make computers more intelligent. One of the basic requirements 
for any intelligent behaviour is learning. Therefore, machine learning is one of the major 
branches of artificial intelligence and is rapidly growing.  Machine learning algorithms were 
from the very beginning designed and used to analyze medical datasets (Kononenko, 2001). 
Today, machine learning is able to provide various vital automated tools for intelligent data 
analysis in the medical community. In the future, intelligent data analysis will play an even more 
important role due to the large amount of information produced and stored by modern 
technology. Current machine learning algorithms provide tools that can significantly help 
medical practitioners to reveal interesting relationships in their data (Kononenko, 2001). 
Machine learning based diagnostic instruments will be used by physicians and health care 
	 21	
professionals as any other tool to aid in diagnosis. These tools will be a source of possibly useful 
information that helps to improve diagnostic accuracy. The final responsibility and judgement 
whether to accept or reject this information can still remain with the physician. There have been 
various automated techniques that have been experimented in the pain domain.  
Today, modern hospitals are well equipped with monitoring and other data collection 
devices, and data is gathered and shared in large information systems. Machine learning 
technology is currently well suited for analyzing medical data, and in particular there is a lot of 
work done in medical diagnosis in small specialised diagnostic problems. Even though the 
devices to collect data are present, it is important to utilize these resources in the right manner to 
make better clinical decision support systems for clinicians to solve problems such as inadequate 
pain management. For the functionality of these systems, the medical diagnostic knowledge can 
be automatically derived from the description of cases solved in the past. The derived classifier 
can then be used either to assist the physician when diagnosing new patients in order to improve 
the diagnostic speed, accuracy and/or reliability (Kononenko, 2001). 
For a machine learning system to be useful in solving medical diagnostic tasks, the 
following features should be present: good performance, the ability to appropriately deal with 
missing data and with noisy data (errors in data), the transparency of diagnostic knowledge, the 
ability to explain decisions, and the ability of the algorithm to reduce the number of tests 
necessary to obtain reliable diagnosis (Kononenko, 2001). 
To advance the development of a physiology-based pain measure, neuroimaging methods 
have been applied to pain management. It can be beneficial to incorporate machine-learning 
techniques, and to investigate the complex interplay of brain regions in mediating the experience 
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of pain (Brown et al., 2011). The use of functional MRI (fMRI) in detecting the presence of pain 
may be strengthened by incorporating machine learning algorithms. Machine learning algorithms 
such as for example a support vector machine (SVM), can allow predictive models to be trained 
with a known set of stimuli when detecting pain. Support vector machines and related machine 
learning algorithms are versatile tools that can learn complex relationships between multiple 
inputs. Therefore, these systems and tools are very well suited for integrating into them various 
factors to make classification. These are more accurate than what would result from the 
investigation of one data source in isolation (Brown et al., 2011). 
Marquand and colleagues were the first to apply these neuroimaging fMRI techniques 
and machine learning algorithms to the area of pain measurement (Marquand et al., 2010). In 
their study, healthy individuals were exposed to thermal stimuli presented at heat perception 
threshold, pain perception threshold, and pain tolerance. Machine learning algorithms were 
trained on fMRI data and used to predict self-reported pain for each participant individually 
(Marquand et al., 2010). This study provided an important advancement in pain measurement, 
demonstrating that machine learning algorithms could be used to assess an individual’s pain, if 
trained using fMRI data from that same individual. 
To extend this work of Marquand et al., it would be useful to demonstrate that 
physiology-based pain assessment, using fMRI data and machine learning algorithms, can 
classify pain accurately without relying on self-report data from the individual that is being 
tested. If, for example, a SVM model could be trained on one set of neonates, and used to 
accurately classify pain in different premature infants, then its performance would not depend on 
the test neonates self-report. Therefore, while there may be considerable individual differences in 
the experience of pain and in patterns of brain activity induced by pain, there are nonetheless a 
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core set of pain-induced responses in the brain that may prove to be universal (Brown et al., 
2011).  
Objective pain measures are observational instruments that can be categorized as 
unidimensional or multidimensional. Researchers believe that a multidimensional objective 
measure aids better results as it evaluates two or more pain dimensions (e.g. behaviours and 
physiologic responses) and it has several domains within each dimension. In a comprehensive 
review of neonatal/paediatric objective pain measures, the authors concluded that 
multidimensional measures were more useful clinically and that no single domain was reliable or 
valid when used alone (Li, Puntillo, & Miaskowski, 2008). The goal in utilizing 
multidimensional measures would be to yield accuracy levels as close to 100% as possible. 
2.3.1 Ontology  
Ontologies are a very popular field in the pain domain. Ontological engineering, dealing with 
developing and using ontology, has become an important research focus in information science. 
In recent years, use of ontology as a mechanism for representing knowledge in clinical decision 
support systems (CDSS) has gained momentum and has become more common in supporting 
and solving decision problems as complex as pain (Noy, Rubin, & Musen, 2004). 
An information system is intended to be a representation of a world as perceived by a 
human or a group of humans (Wand & Weber, 2004). However, since healthcare is a very 
diverse and complex system, it is essential that healthcare information systems represent that 
kind of complexity. Ontologies are representations of concepts and relationships in a domain 
area and are important to the information systems field in that they have been described as the 
best base for building theories about information systems representations. There are three 
different ways ontologies can be used in information systems design. Firstly, as a benchmark to 
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evaluate models used in systems development and secondly to provide a set of concepts to model 
systems and to reason about their characteristics and finally to define the meaning of information 
that will be available through an information system (Kuziemsky, Downing, Black, & Lau, 
2007).  
One particular study used the grounded theory approach, which includes three systematic 
coding cycles: open, axial and selective coding. The ontology represents a means of formalizing 
the richness obtained through the grounded theory coding by applying a systematic way of 
organizing the concepts as well as establishing the relationships between them (Kuziemsky et al., 
2007). The study also makes a contribution to ontology information systems research by 
illustrating how the grounded theory approach can be used to design an ontology that contains an 
empirically derived vocabulary, models the concepts and relationships in a complex domain area 
and also details the processes and information within the ontology (Kuziemsky et al., 2007). 
2.3.2 Relevance Vector Machine (RVM) 
Infants are unable to directly report their level of pain, and hence, physicians and nurses are 
responsible for pain assessment for neonates. Pain and distress behaviours in neonates, include 
facial expression, cry, and body movement, and a series of methods have been suggested to 
objectively assess pain in neonates based on the aforementioned behaviours. Correct 
interpretation of the facial expressions of the patient and its correlation with pain is a 
fundamental step in designing an automated pain assessment management system. However, by 
adding other pain behaviours, including head movement and the movement of other body parts, 
along with physiological indicators of pain, such as heart rate, blood pressure, and respiratory 
rate responses should make the pain detection system more accurate.  
Recent advancements in pattern recognition techniques using Relevance Vector Machine 
(RVM) learning techniques can assist physicians and nurses in assessing pain by constantly 
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monitoring the patient and providing the clinician with quantifiable data for pain management 
(Gholami, Haddad, & Tannenbaum, 2010). In one particular study, the researchers used the 
RVM classification technique to distinguish pain from non-pain in neonates as well as assess 
their pain intensity levels. 
The RVM algorithm can potentially be useful in assessing sedation and agitation in the 
NICU (Gholami et al., 2010). The fundamental limitations in sedation and agitation assessment 
in the NICU stem from subjective assessment criteria, rather than quantifiable, measurable data 
for NICU sedation. An automatic sedation and pain assessment system can be used within a 
decision support system, which can also provide automated sedation and analgesia in the ICU 
(Gholami et al., 2010). However, a system such as this is yet to be implemented in the NICU. 
Algorithms such as RVM can aid in creating an automated system for neonatal pain 
measurement.  
2.3.3 Statistical Systems 
There are many different statistical techniques that have also been discussed in the pain 
literature. One such literature review looked at and tested machine-learning techniques for 
abdominal pain in order to improve standard statistical systems. This study highlighted various 
different statistical systems that can be used to measure pain. The researcher’s investigation was 
based on a prospective clinical database with 1254 cases, 46 diagnostic parameters and 15 
diagnoses (Ohmann, Moustakis, Yang, & Lang, 1996).  
 
Following are the different automated rule induction techniques that were presented (Ohmann et 
al., 1996). 
1. ID3: construction of a decision tree via the iterative deployment of four rules. 
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2. C4.5: represents a system that implements the ID3 approach but is better in that it uses 
decision tree simplification and or pruning.  
 
3. NewId: represents another implementation of ID3. Understands priority scheme. 
 
4. ITRULE: uses the information-theoretic J-measure to find the most informative set of 
rules from an input data set. The algorithm searches the space for possible rules and 
calculates the information contents of the rules (J-measure).  
 
5. CN2: represents a star generator machine learning system.  
 
In this study, for evaluation purposes, the database of 1254 patients was randomly split into a 
training set and a separate test set.  The standard model and all algorithms for automatic rule 
generation mentioned above were trained on the training set and separately evaluated on the test 
set (Ohmann et al., 1996).  
Detailed analyses showed that the clinical impact of computer-aided diagnosis is a 
combined effect of audit, structured data collection, feedback, education and the computer. 
Automatic knowledge acquisition techniques used to develop rule-based systems from clinical 
data have been applied with good success in several other clinical areas.  
Furthermore, another study done by same set of authors implemented this knowledge and 
used it to describe a knowledge-based system for the diagnosis of acute abdominal pain, in which 
scores and rule sets were integrated. This system in particular was linked to a documentation 
program via a medical data dictionary and allowed an online application of knowledge modules 
to clinical data (Eich, Ohmann, & Lang, 1997). 
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In this study, different rule sets were generated by automatic rule generation (C4.5) from 
a prospective database. The rule sets and two published diagnostic scores were evaluated on a 
test set, resulting in a diagnostic accuracy of 57 % for a general knowledge module and between 
44 and 88 % for specific knowledge modules (Eich et al., 1997). In the first approach, rule-based 
sets were generated by machine learning techniques from clinical databases (automatic rule 
generation). The algorithm used was C4.5, representing a system similar to the ID3 approach. 
For testing of the rule sets generated by C4.5, a prospective European database with 10233 cases 
was used (Eich et al., 1997). The database was split into training set and test set. The whole 
system consisted of 3 program modules. A data dictionary, documentation program and a 
Knowledge Based System (KBS) (Eich et al., 1997). The data dictionary is a controlled 
vocabulary by which the integration of the documentation module and the KBS can be achieved. 
The second module was designed to collect data in clinical studies. In this documentation 
program, the authors carried out several prospective evaluation studies where their aim was to 
build up a quality-controlled prospective database on which they can apply knowledge-based 
methods. The third component of this system was the KBS, which was used for diagnostic 
support. They integrated rule-based systems, which automatically generate rules from 
prospective databases and scores. Sets of rules were created through the C4.5 algorithm. The 
KBS has a human interface and can be used as a stand-alone system. 
2.3.4 Clinical decision support/ web based systems 
The first Clinical Decision Support systems (CDSS) were standalone systems that were running 
separately from other hospital systems. They evolved into integrated systems where decision 
support was embedded into hospital information systems (e.g., offering support in such clinical 
areas as laboratory, nurse charting, radiology or pharmacy). Then, the integrated systems evolved 
into separated systems with shareable information and decision support content (Farion et al., 
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2009). One study focused on the design of a clinical decision support system (CDSS) that 
supports heterogeneous clinical decision problems and runs on multiple computing platforms. 
This is important as in today’s health care settings; practices have become interpersonal and 
collaborative as opposed to homozygous decision-making. 
The proposed design of this study provided a common framework that facilitated 
development of diversified clinical applications running seamlessly on a variety of computing 
platforms. It was prototyped for two clinical decision problems and settings (triage of acute pain 
in the emergency department and postoperative management of radical prostatectomy on the 
hospital ward) and implemented on two computing platforms – desktop and handheld computers 
(Farion et al., 2009). In a previous study of the authors, a system named MET1 (Mobile 
Emergency Triage) was designed to help with management of paediatric patients using 
information about their history, physical examination and a limited number of laboratory tests 
(Farion et al., 2009). MET1 included two clinical applications (supporting triage of paediatric 
abdominal pain and paediatric scrotal pain). The system was able to run on handheld computers. 
However, MET1 was designed to support set of homogeneous decision problems only in a single 
setting such as the emergency department (ED) and to operate on a single computing platform (a 
handheld computer). 
In the process, the researchers then proposed a new clinical decision support system 
design (referred to as MET2) that represents the next generation of CDSS that can make 
heterogeneous decisions. The researchers used ontology driven design to represent essential 
components of a CDSS. The two major architectural components of this design were the 
application repository and the executor. The application repository managed and stored the 
available application models. The executor created applications according to their application 
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models and executed them (Farion et al., 2009). Typically, upon the ED physician’s request, the 
executor retrieved an appropriate application model from the application repository and created 
the user interface according to the data ontology using components from the interface repository. 
Overall in this study, they have updated the previous MET1 system to a MET2 system, 
which introduces two new components: interface ontology and the configuration ontology. In the 
MET 2 system it encompasses data, support, interface and configuration models. In this new 
system, they also introduced the Entity-Attribute Value (EAV) approach to structure clinical 
information as it allows for more flexible and effective handling of heterogeneous data (Farion et 
al., 2009). The authors proposed a multi-device architecture for electronic information 
processing and communication in the clinical setting. A similar approach is also proposed by 
another new paradigm: activity-based computing. This approach also highlights clinical 
computing that considers user activities (tasks) as first class objects in a computing environment. 
A new-generation CDSS should be able to support heterogeneous decision problems (in 
particular those that require heterogeneous decision models and solvers) at different settings and 
to execute seamlessly on multiple computing platforms. This is important in the neonatal pain 
domain, as pain can be a result of many different factors. For this reason, the system 
implemented should be able to make heterogeneous decisions.  
Following the concept of clinical decision support systems, one paper described a 
prototype clinical decision support system (CDSS) for risk stratification of patients with cardiac 
chest pain. The researchers employed a belief Rule-base Inference Methodology using the 
Evidential Reasoning approach (RIMER) for developing an intelligent CDSS (Kong et al., 
2012).  In this RIMER approach, belief rule base was employed to model clinical domain 
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knowledge under uncertainties. Such a rule base was capable of capturing vagueness, 
incompleteness, and nonlinear causal relationships. 
In this clinical decision support study, the researchers adopted a unique web-based three 
layer architecture in the prototype design of the clinical decision support system design (Kong et 
al., 2012). Three-layer architecture of a web-based intelligent clinical decision support system 
should include four different system components: friendly web-based user interfaces, inference 
engine, knowledge base, and database. The core components implemented in the belief rule-
based system prototype in this study include web-based user interface, database, inference engine 
and knowledge base. 
Benefit of a web-based decision support system is that it can deliver suggestions or 
recommendations generated from the system to a much broader audience. Web-based decision 
support system in clinical areas can have many advantages such as provision of easy access to 
computerized decision support for clinicians in geographically different places. It can also 
provide easy dissemination of clinical domain knowledge and patient data among different 
clinical application systems which are linked through internet (Kong et al., 2012). Increase in the 
use of information technology (IT) in health care, particularly the introduction of clinical 
decision support systems, can help simplify the health care process and substantially facilitate 
clinical practice and reduce medical errors. Even though clinical decision support systems are 
promising in helping facilitate evidence based medicine and reducing patient adverse outcomes, 
there are challenges in this research area that have made few clinical decision support systems 
widely applied in practice (Kong et al., 2012). 
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2.3.5 Biopotentials  
One study used the expression of pain and its biopotential parameters to show how pain can be 
measured. The researchers collected a database using visual and biopotential signals to advance 
an automated pain recognition system, to determine its theoretical testing quality, and to 
optimize its performance (Walter et al., 2013). For this purpose, participants were subjected to 
painful heat stimuli under controlled conditions. This study had many unique properties such as 
the use of highly controlled pain stimulation, multiple camera setup, recording of depth 
information via a camera and most importantly multimodal detection such as simultaneous data 
collection on skin conductance level, electrocardiogram (ECG), electromyogram (EMG), and 
electroencephalography (EEG) (Walter et al., 2013). 
This biopotential study’s aim was to select the features and feature patterns that 
contribute to the highest recognition rate for pain recognition, quantification and dissociation 
from emotion. A range of data fusion procedures was tested for this. Overall, the study used 
biopotential and video analyses to measure pain (Walter et al., 2013). The authors were moving 
towards the vision of creating an automatic system for an objective measurement of pain, which 
can facilitate pain monitoring, logging and support in a clinical environment. The authors named 
this “pain computing”.  
2.3.6 Facial recognition 
In the last few years in the neonatal pain area, there has been great focus on automated facial 
recognition scales.  Various pain assessment measures (tools, instruments, etc.) based on facial 
expressions of pain have been developed (Yuan, Bao, & Guanming, 2008). This has proved to be 
a popular area of research as an automated recognition of facial expressions of pain does not 
require reliance on health professionals that has great medical significance. The objective of the 
facial recognition study done by Yuan et al. is to bypass the observational problems by 
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developing a machine classification system to diagnose neonatal facial expressions of pain(Yuan 
et al., 2008). In this particular study, they employ an expressive feature, the Gabor feature, to the 
representation of neonatal faces. Each neonatal facial image is convoluted with the 2D Gabor 
Filters to extract 412,160 Gabor features (Yuan et al., 2008).  The Gabor features are obtained by 
convoluting the image with a series of Gabor filers. Gabor filters extract features from different 
orientation and different scales (Yuan et al., 2008). Image analysis with Gabour filters is thought 
to be similar to perception in the human visual system, which is why it is used in this case.  
An automated facial expression analysis system usually consists of three parts: face 
detection, facial feature extraction/representation and classification. In this experiment by Yuan 
and colleagues (2008), they attempted to distinguish cry expressions that were in response to 
pain from those cry expressions that were in response to a less noxious stimulus. Thus, two 
stimuli were included in this study: heel puncture and transporting the neonate from one crib to 
another. In the feature extraction stage, 2D Gabor filter were applied to extract the expression 
features from facial images. Finally, in the feature selection and classification stage, the proposed 
HybridBoost is applied to select the most informative features/weak classifiers, and by this a 
hierarchy of strong classifiers are constructed (Yuan et al., 2008). Experiments with 510 neonatal 
expression images showed that the proposed method in this study was effective and only 30 
Gabor features were enough to achieve good classification performance (Yuan et al., 2008).  The 
recognition rate of pain versus non-pain was up to 88%. Over the last decades, such automatic 
facial expression analysis has become an active research field that shows high potential in many 
areas, such as the automated assessment of neonatal pain. 
Another facial recognition study describes the Infant Classification Of Pain Expressions 
(COPE) Project (Brahnam et al., 2007). A short-term goal of this project was to investigate the 
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feasibility of using holistic face recognition techniques to detect pain signals in newborn facial 
displays. The long-term goal of the authors was to develop working systems that can be 
implemented in neonatal units (Brahnam et al., 2007). Selection of stimuli used to provoke facial 
displays in the neonates was of critical importance in this study.  For the initial infant study, four 
noxious stimuli were selected: the puncture of a heel lance, friction, produced by swabbing on 
the external lateral surface of the heel, an air stimulus on the nose and lastly transport from one 
crib to another (Brahnam et al., 2007).  The objective of performing these procedures was to 
obtain a representative and challenging set of images for evaluating face classification systems of 
pain.  
2.4 Neurological Indicators 
Pain causes detectable biochemical, physiological, and behavioural changes during the rapid 
development phase of the central nervous system.  Repeated and long-term experiences of pain 
have adverse effects on brain development and cognitive development as well as on later pain 
behaviour manifestation and pain sensations. Thus, it is important to alleviate pain during 
hospitalisation in order to promote the optimal neurological and functional development of 
preterm infants (Korhonen et al., 2013).  
Brain imaging is a very active area of pain research that can aid in leading to improved 
pain measurement in the future (Apkarian, Bushnell, Treede, & Zubieta, 2005; Borsook & 
Becerra, 2006; Slater et al., 2006). Some imaging methods that can be used for this purpose are 
positron-emission tomography, single-photon emission computed tomography, near infrared 
spectroscopy, and functional magnetic resonance imaging (Berde & McGrath, 2009). It can also 
be possible to detect signals reflecting regional brain glucose use, blood flow, or regional ratios 
of oxy- to deoxy-hemoglobin, respectively, as surrogate measures of regional neuronal metabolic 
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activity (Berde & McGrath, 2009). Furthermore, magnetic or electric source potential mapping 
or processed electroencephalographic measures can also be used as surrogate measures of 
regional brain electrical activity (Berde & McGrath, 2009). In the mid-to- late 1980s, infant 
behavioural researchers used cortisol levels to assess behavioural responses to various stressors. 
Stress response to handling, pain response to heel stick, and circumcision, as well as the effects 
of biomedical status on response were key issues. Cortisol responses were noted to be greater 
following painful procedures than routine handling, and behavioural responses did not correlate 
well with peak cortisol levels (Herrington, Olomu, & Geller, 2004). 
A research study done by Slater and colleagues in 2008 assessed the association between 
cortical pain responses in young infants and currently used tools for the assessment of pain in 
these infants (Slater et al., 2008). They were able to record infant cortical activity in response to 
noxious stimulation, which provided for a first of its kind opportunity to look at the relationship 
between clinical pain assessment scores, on the basis of behavioural and physiological responses, 
with measurements of pain processing in the brain.  The researchers presented an analysis of the 
association between the cortical haemodynamic activity and the components of a clinical pain 
assessment tool (PIPP) (Slater et al., 2008).  
Behaviours to communicate pain require motor responses to sensory and emotional 
stimuli (Slater et al., 2008). The maturity of the premature infant to this complex system is not 
clearly understood currently.  The results of the study by Slater (2008) raise further awareness of 
the ability of infants to experience pain and highlight the possibility that pain assessment based 
on behavioural tools alone may underestimate the pain response in infants. The researchers also 
concluded that positive brain response to painful stimulus could occur even in the absence of any 
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facial expression. These conclusions are important as they obtain evidence for the urgent need to 
provide physiological changes in a greater focus in the detection of pain in neonatal infants. 
2.5 Conclusion 
This chapter has presented various studies that have outlined that machine-based systems can be 
used to detect and analyze physiological changes associated with pain such as increase in heart 
rate. Numerous automated approaches have been presented to assess pain based on analysis of 
physiological indicators (Brown et al., 2011; Lindh et al., 1999). Studies have shown that there is 
high correlation between pain/discomfort and changes in vital signs (e.g., heart rate increasing) 
(Janig, 1995). Many of the automated systems already in place such as the traditional assessment 
of infant’s crying and facial recognition systems are biased and depend totally on the observer’s 
subjective judgement (Riddell & Craig, 2007). Therefore, using the knowledge from this chapter 
and developing a quantitative and minimally biased pain assessment system that can 
continuously provide feedback is important. It is important to use the knowledge and techniques 
presented in this chapter to design a pain assessment scale that can be standardized.  There is 











Chapter 3 - Artemis 
This chapter presents The Artemis platform used in this thesis. The Artemis framework is a 
framework for concurrent multi-patient, multi-diagnosis and multi-stream temporal analysis in 
real-time for clinical decision support as well as prospective and retrospective clinical research 
(Blount et al., 2010). The Artemis framework relies on the acquisition of physiological data from 
existing bedside medical devices contained within the NICU as the data are generated. These 
devices, which are already enabled to output their data for collection, can be connected via an 
Ethernet and/or serial port. Sources of data include bedside physiological monitoring devices, 
medical equipment such as ventilators and infusion pumps, and clinical information management 
systems (CIMS), which house the patient’s electronic medical record and laboratory results 
(Blount et al., 2010; McGregor, 2013; McGregor, Catley, James, & Padbury, 2011). The analytic 
results provide clinicians with integrated temporal summaries of events (McGregor, Catley, 
James, et al., 2011), which delivers advanced clinical decision support. Since 2009, the Artemis 
system has been deployed in several NICUs of various hospitals. In such clinical settings, the 
Artemis system has the ability to acquire, collect, analyze, and store data containing 
electrocardiogram (ECG), heart rate (HR), respiratory rate (RR), oxygen saturation (SpO2), and 
blood pressure (BP) streams as well as Clinical Information Management System (CIMS) 
observations for clinical research (Blount et al., 2010).  
The Artemis framework is outlined in Figure 1 (McGregor, Catley, James, et al., 2011). 
The data acquisition component enables the provision of real-time synchronous medical device 
data and asynchronous CIMS data to be refined, formatted and standardized. Subsequently, this 
data is forwarded for analysis within the Online Analysis component that operates in real-time 










For this real-time component, Artemis employs IBM's InfoSphere Streams, a novel streaming 
middleware system that processes data in real-time and then enables data storage within the Data 
Persistency component (McGregor, Catley, & James, 2011). Consequently, the system is capable 
of processing and storing both the raw data and derived data from multiple infant sources at the 
rate at which the data are generated (Blount et al., 2010). Stream processing is supported by 
IBM's Stream Processing Language (SPL), which is the system specific programming language 
for IBM's InfoSphere Streams middleware (Blount et al., 2010). For the Knowledge Extraction 
component, Artemis utilizes a newly proposed temporal data mining approach (McGregor, 
Catley, & James, 2012). This component supports the discovery of condition onset behaviours in 
physiological data streams and associated clinical data. New knowledge, once tested and derived 
from rigorous clinical research techniques, is transferred for use within the Online Analysis 




Overall, Artemis can be defined as an extensive and cultivated Big Data informatics 
platform within which compatible algorithms, such as the one proposed in this thesis for pain 
assessment, can be functionally deployed. “Big Data” refers to datasets whose size is beyond the 
ability of typical database software tools to capture, store, manage, and analyze (Manyika et al., 
2011). Online health analytics have significant relevance in the critical care domain. The 
enormous quantities of complex physiological data continuously produced by critical care 
monitors and equipment exceeds the clinician’s capacity for processing (McGregor, 2013; 
McGregor, Catley, James, et al., 2011). The use and adoption of online health analytics has great 
potential to enable quality improvement. Such analytics enable the real-time processing of early 
prognosticators of impending clinical deterioration (McGregor, 2013; McGregor, Catley, James, 
et al., 2011) and perform as an early warning system. The application of online health analytics 
promotes timely intervention and improved outcomes for patients (McGregor, 2013; McGregor, 
Catley, James, et al., 2011). The utilization of a similar system can be useful in additional research 
areas and future retrospective research opportunities such as that presented in this thesis. The work 
presented in this thesis, is part of a larger Artemis project, which is ongoing at the Health Informatics 
Research Lab at University of Ontario Institute of Technology (UOIT). Within the Artemis project, 
many projects have been completed within varied areas of research, which focus on a real-time 
algorithm design. For example, a similar algorithm design has been used for monitoring conditions 
related to retinopathy of prematurity (Cirelli, McGregor, Graydon, & James, 2013). Additionally, 
such algorithms have been incorporated into the automated monitoring techniques for apnoea of 
prematurity (Catley, Smith, McGregor, James, & Eklund, 2011) and detection of sleep-wake 
cycling patterns in neonates (Eklund et al., 2014). Such projects depict the optimistic possibility 
of Artemis in providing a significant contribution to clinical diagnostics with physiological data. 
Similarly, this thesis work will demonstrate the utility of the Artemis platform for the effective 
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detection and monitoring of pain within the neonatal population in the future. The Artemis platform 
has been used previously for preliminary work on this subject. Such work focused on designing rules 
to create a novel pain profile, and also includes a pilot retrospective study compared between 
Artemis generated pain score and a pain score that was in use at The Hospital for Sick Children, 
Toronto, Canada (Naik, Bressan, James, & McGregor, 2013; Naik & McGregor, 2014; Naik et al., 
2014). Using this background work with Artemis capabilities, it is possible to design an algorithm 
unique to this research that can be deployed within Artemis to create a pain detection system that 













Chapter 4 - Methodology 
Literature has demonstrated that untreated pain in premature infants may cause long-term 
effects associated with changes in the nervous system, pain perception, sleep disturbances, 
feeding problems, and chronic pain syndromes (Slater et al., 2008). The inexistence of a gold 
standard within pain management, the complexity of the premature infant and the rapid 
deterioration of the fragile neonatal population poses challenges that must be overcome in order 
to achieve optimal pain management tools. For this reason, this chapter will introduce several 
methods to achieve such goals.  
The methodology in this chapter is presented in two phases. In Phase I, a data preparation 
phase is introduced to demonstrate the work in which retrospective analysis is completed using 
the data collected from the Artemis platform in the DB2 system. In this data preparation phase, 
the abstractions were put into individual streams to look for features in the physiological streams. 
The data preparation results were used during the second phase, where a data model was created 
using Microsoft Excel. Phase II involved combining the, abstractions and features from the data 
preparation phase in order to compute an automated partial pain score based on big data analytics 
and quantifiable scoring from the streams prepared in data preparation phase (Heart Rate (HR), 
Oxygen Saturation (SpO2) and Gestational Age (GA)). The steps outlined in this chapter are 
completed in order to carry out experiments in chapter 5. 
 The population for this study was twenty-three premature infants; thirteen males and ten 
females; gestational age 33.2 ± 5.41 weeks and birth weight 2060 ± 910 grams. Data are 
presented as mean ± SD.  
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4.1 Phase I: Data preparation  
Demographic data were extracted from the medical records such as GA, birth weight, gender, 
admission diagnosis, PIPP and surgical information. This data was collected for twenty-three 
subjects, and physiological data for heart rate (HR) and oxygen saturation (SpO2) were streamed 
from The Artemis Platform. Physiological data from the NICU bedside devices were captured in 
real-time. The approach to automation involved blocking the second-by-second data into a one-
hour window to construct an hourly partial PIPP score.  
Excel was used for the construction of a series of queries that would each create a 
temporal abstraction for a given hour. As noted in the discussion in chapter 7, this process would 
be replaced by Infosphere streams code that can run in real-time and has windowing capabilities. 
For each subject, the following steps were performed to extract and organize the data for analysis 
to enable hour-by-hour analysis for the physiological data components of HR and SpO2:   
1. The start and end date and time to be used for each subject was identified and was then 
converted to GMT epoch timestamp to run the query. The identification of start and end 
epochs for every hour was essential. Data preparation file was created in Microsoft Excel® 
for each subject separately.  
2. The epochs were put in a row for each hour to match the original date and time. The date and 
time was converted to epoch with the following equation in Microsoft Excel®: 






Date & Time (DD/MM/YY 
HH:MM) EPOCH  
09/03/2010 20:00 1268164800 
09/03/2010 21:00 1268168400 
09/03/2010 22:00 1268172000 
09/03/2010 23:00 1268175600 
10/03/2010 0:00 1268179200 
 
3. Since there are 3600 seconds in one hour, generation of the start of the hour epoch as well as 
the end of the hour epoch is important. One column was created for the start of the hour 
epoch, using the following formula in Microsoft Excel®: 
('567ℎ	(69):);%<	&)*') − 3601)		        Equation 2 
Another column was created for end of the hour epoch for which the following formula was 
used in Microsoft Excel®: 
('567ℎ	(69):);%<	&)*') + 1)               Equation 3 
This ensured that full data for within the hour was collected. Table 3 shows an overview of 
the preparation sheet for data extraction. 
Table	3.	Data	preparation	sheet	for	EPOCH	
Patient ID Date & Time  
EPOCH (original 
time) 




Subject 1 09/03/2010 20:00 1268164800 1268161199 1268164801 
Subject 1 09/03/2010 21:00 1268168400 1268164799 1268168401 
Subject 1 09/03/2010 22:00 1268172000 1268168399 1268172001 
Subject 1 09/03/2010 23:00 1268175600 1268171999 1268175601 
Subject 1 10/03/2010 0:00 1268179200 1268175599 1268179201 
 
4. The query was run in STDM framework instantiated within The Artemis Platform in the 
knowledge discovery component to extract results for HR and SpO2 for each hour. The 
following formula was used in Microsoft Excel®: 
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=CONCATENATE ("select patientid, instancestart, avg(hrvalue) as AVG, min(hrvalue) 
as MIN, max(hrvalue) as MAX, stddev(hrvalue) as STDDEV, count(hrvalue) as COUNT 
from (select patientid, '", D2, "' as instancestart, timestamp, hrvalue from db2inst1.rawhr 
where patientid = 'N",A2, "' and timestamp > ", E2, " and timestamp < ", F2, ") group by 
patientid, instancestart ") 
 
5. The query was run for each hour for each subject. This extracted per second data for every 









16:00 1268150400 162.49 102 199 15.50 3516 
Subject 1 
09/03/2010 
17:00 1268154000 24004.3 74 8388607 446660 3517 
Subject 1 
09/03/2010 
18:00 1268157600 8388607 8388607 8388607 0 161 
Subject 1 
09/03/2010 
20:00 1268164800 131.1 119 138 2.97 902 
Subject 1 
09/03/2010 
21:00 1268168400 139.29 128 166 5.34 3517 
Subject 1 
09/03/2010 
22:00 1268172000 142.50 83 173 8.45 3516 
Subject 1 
09/03/2010 
23:00 1268175600 140.93 115 155 3.68 3511 
 
6. To clean the data, the query was updated and changed to exclude the artifacts. If any artifacts 
were found, they were removed for each hour for both HR and SpO2 and the total counts of 
the rows was recorded. Following query was used to remove artifacts in Microsoft Excel®: 
 
 =CONCATENATE("select patientid, instancestart, avg(hrvalue) as AVG, min(hrvalue) 
as MIN, max(hrvalue) as MAX, stddev(hrvalue) as STDDEV, count(hrvalue) as COUNT 
from (select patientid, '", D2, "' as instancestart, timestamp, hrvalue from db2inst1.rawhr 
where patientid = 'N",A2, "' and timestamp > ", F2, " and timestamp < ", G2, " and 
hrvalue <> 8388607) group by patientid, instancestart") 
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7. After removal of artifacts (if any), the final output provided per second data for HR, which 
was then summarized into average, minimum, maximum, standard deviation and number of 





TIME EPOCH AVG MIN MAX STD DEV COUNT 
Subject 1 09/03/2010 16:00 1268150400 162.49 102 199 15.499 3516 
Subject 1 09/03/2010 17:00 1268154000 153.10 74 177 8.066 3507 
Subject 1 09/03/2010 20:00 1268164800 131.10 119 138 2.968 902 
Subject 1 09/03/2010 21:00 1268168400 139.29 128 166 5.336 3517 
Subject 1 09/03/2010 22:00 1268172000 142.50 83 173 8.449 3516 
Subject 1 09/03/2010 23:00 1268175600 140.93 115 155 3.682 3511 
Subject 1 10/03/2010 0:00 1268179200 139.57 122 156 3.893 3451 
 
8. Similarly, an output was provided for per second data for SpO2, which was then summarized 
into average, minimum, maximum, standard deviation and number of rows (counts) for each 
hour. Table 6 shows the output sheet for SpO2. 
Table	6.	Output	sheet	for	SpO2	without	artifacts	
PATIENT 
ID DATE & TIME EPOCH AVG MIN MAX 
STD 
DEV COUNT 
Subject 1 09/03/2010 16:00 1268150400 94.92 78 100 4.008 3516 
Subject 1 09/03/2010 17:00 1268154000 95.12 83 98 2.162 3504 
Subject 1 09/03/2010 20:00 1268164800 95.24 77 99 5.042 902 
Subject 1 09/03/2010 21:00 1268168400 94.16 78 99 2.712 3516 
Subject 1 09/03/2010 22:00 1268172000 94.56 71 97 3.859 3506 
Subject 1 09/03/2010 23:00 1268175600 94.13 86 96 1.228 3511 
Subject 1 10/03/2010 0:00 1268179200 92.23 85 95 1.639 3453 
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9. After this, the PIPP scores, when available, were manually inputted into the rows (hours) 
(PIPP scores were collected by nurses and extracted for research by a research assistant from 
the CIMS system at SickKids Hospital). 
10. GA was also calculated based on the age of the infant at the time of first collected PIPP 
score. Based on this calculation, the GA was changed over time. Table 7 shows the final 





TIME EPOCH AVG MIN MAX 
STD 
DEV N PIPP GA 
Subject 1 09/03/2010 16:00 1268150400 162.49 102 199 15.499 3516 8 28 
Subject 1 09/03/2010 17:00 1268154000 153.10 74 177 8.066 3507   28 
Subject 1 09/03/2010 20:00 1268164800 131.10 119 138 2.968 902 5 
28 
Subject 1 09/03/2010 21:00 1268168400 139.29 128 166 5.336 3517   28 
Subject 1 09/03/2010 22:00 1268172000 142.50 83 173 8.449 3516   28 
Subject 1 09/03/2010 23:00 1268175600 140.93 115 155 3.682 3511   28 
Subject 1 10/03/2010 0:00 1268179200 139.57 122 156 3.893 3451 10 28 
 
4.2 Phase II: Data Model 
Following the data preparation phase, a data model was created based on the Premature Infant 
Pain Profile (PIPP) using Artemis data. The PIPP scale was chosen as the base comparison scale 
for this thesis because the clinical institution (The Hospital for Sick Children, Toronto, Canada) 
that was associated with this study used this particular scale in their clinical setting. The PIPP 
scores were collected from The Hospital for Sick Children’s NICU records. Nurses collected 
PIPP scores in a handwritten format. These records were retrospectively examined and the scores 
were recorded for research purposes. 
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The PIPP scale was used in correlation with Artemis data to compute a total score for 
each hour using maximum HR, minimum SpO2 and GA. Since PIPP is the base scale used in this 
study, the scale was used to explore and demonstrate a new scoring system. Following this, 
Artemis Premature Infant Pain Profile (APIPP) was created. By depicting the parameters of 
scoring from the already in place PIPP scale, an attempt was made to create a model scoring 
system using The Artemis Platform. 
4.2.1 Premature Infant Pain Profile (PIPP)  
The Premature Infant Pain Profile (PIPP) is a behavioural and physiological multidimensional 
assessment tool, which provides a measure of the premature infant’s response to pain (Stevens, 
Johnston, Petryshen, & Taddio, 1996). Scoring indicators include gestational age, behavioural 
states and physiological factors. The presence or degree of change/pain is rated on a four-point 
scale, which includes seven indicators. The indicators include upper facial activity, physiological 
activity and behavioural state. The scale ranges from zero (minimum score) to 21 (maximum 
score). The PIPP scale was the first of its kind multidimensional premature infant pain assessing 
scale. 
The PIPP is one of the very few scales that accounts for the infant’s gestational age, thus 
allowing the distinction among mature, full-term and, preterm infants (Gallo, 2003). PIPP was 
developed using data from four studies involving 238 neonates undergoing heel stick, where 
such studies identified the indicators of PIPP while establishing the validity of the instrument 
(Franck & Miaskowski, 1997).  
When Stevens et al. created the PIPP scale, they reviewed previous literature and 
concluded that previous scales were mostly one-dimensional and only included behavioural 
responses to pain (Stevens et al., 1996). These scales did not include the physiological indicators 
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or factors to modify the pain response. The investigators highlighted a need for multidimensional 
pain measure for premature infants. Hence, the PIPP scale was developed using multiple 
indicators. The PIPP scale was developed and validated using a prospective and retrospective 
design. Indicators of pain were identified by clinical experts and using literature. Indicators were 
retrospectively tested using four existing data sets.  
PIPP provided a sufficient background for this thesis to carry out a case study that 
explores the hypothesis of designing a scoring system using real-time big data analytic 
techniques to quantify pain in the neonatal population. To investigate the research questions for 
this thesis, the election of parameters that will be used for the case study was important. Since 
The Artemis Platform contains the data for both physiological parameters contained within the 
PIPP (HR, SpO2), these particular parameters were included in the design of the novel APIPP 
scale.  
Table	8.	Premature	Infant	Pain	Profile	(PIPP)	


















































































Brow Bulge None Minimum Moderate Maximum  
Eye 
Squeeze 
None Minimum Moderate Maximum  
Nasolabial 
furrow 




Since this thesis presents an approach to automate a physiological scale, the two physiological 
parameters (HR, SpO2) contained within the PIPP scale were used for analysis in the design of 
scoring the new scale APIPP. Gestational age was also included in the APIPP analysis as 
Gestational age has proven to have varying effects on a neonates’ pain perception. Additionally, 
gestational age is a calculable field that is independent of the infant’s state at the bedside.  
4.2.2 Artemis Premature Infant Pain Profile (APIPP) scoring analysis 
APIPP scoring is an attempt to assess the possibility of automation in pain assessment of 
premature infants. For this reason, the two physiological indicators contained within the PIPP 
scale were included in the APIPP scale. The physiological data for HR and SpO2 were also 
readily available in The Artemis platform. Gestational age was also used as a factor for this scale 
as gestational age can have varied effects on how a neonate responds to pain. The APIPP scale 
displayed in Table 9 ranges from zero (minimum score) to 9 (maximum score). 
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																																			Table	9.	Artemis	Premature	Infant	Pain	Profile	(APIPP)	
Indicator 0 1 2 3 Total Score 
Gestational 
Age 












































For this generation of the APIPP Temporal Abstraction, the hourly summary data was used from 
section 4.1. All individual physiological streams data and gestational age data was scored 
individually and then combined in one Microsoft Excel sheet to compute a total APIPP score 
(based on the PIPP scoring criteria) that can be compared to the PIPP score. 
1. First, maximum heart rate, minimum SpO2 and gestational age scores were computed based 
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2. Subsequently, maximum HR, minimum SpO2 and gestational age were summed together to 
calculate a total APIPP score. This score was then compared to the PIPP score recorded by 
nurses at The Hospital for Sick Children, Toronto, Canada.  This APIPP score was computed 
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Overall, this chapter presented the preparation of the dataset that was used to carry out 
experiments in chapter 5. A data model was also created based on the PIPP scale using Artemis 
data. Depicting the scoring rules from the PIPP scale and using the data from The Artemis 
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Platform, a model scoring system was presented (APIPP). The following chapter will 
















Chapter 5 - Case study & Evaluation of Data model 
This chapter presents the implementation of methodology described in chapter 4. This study is a 
retrospective quantitative study conducted with the data collected at The Hospital for Sick 
Children, Toronto, Canada in the Neonatal Intensive Care Unit (NICU). This study was reviewed 
and approved by the Research Ethical Board under REB# 1000036025.  For this analysis, 
physiological data was captured continuously from NICU bedside monitoring devices and was 
streamed for temporal analysis using The Artemis Platform that was discussed earlier. Data was 
extracted between 2010 and 2013 from surgical and non-surgical patients during their stay in the 
NICU. After closely inspecting the data for case study analysis, 13 out of the 23 subjects were 
excluded due to insufficient data. Reasons for exclusion are discussed in more detail in section 
5.2. Overall, total of 10 subjects data was used for experiments.  
Following the creation of the data model and scoring of APIPP, the APIPP score was 
compared to the currently in place PIPP data collection for each subject. An in-depth analysis 
was conducted with the PIPP scores to examine if the APIPP score produces greater, lesser or 
equal results.  
The data for the three main variables analyzed in chapter 5 and 6 are significantly spread out 
with great variability in their data. Following is the breakdown for the ten subjects’ data for GA, 
surgery data and PIPP scores. 
a. Gestational Age:  
Out of ten subjects, three subjects were ‘term infants’ from 37 to 41 weeks; three subjects 
were ‘moderate preterm to late preterm infants’ from 32 to 36 weeks; two were ‘very 
preterm infants’ from 28 to 31 weeks and one was ‘extremely preterm’ with less than 28 
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weeks of gestational age.  Considering the wide distribution of the subjects through the 
spectrum, there is a small number of subjects per gestational age. 
b. Surgery: 
Seven subjects underwent a surgical procedure during their stay in the NICU with a total 
of 2105 lines of data, an average of 301 lines. Three subjects did not undergo surgery 
with a total of 295 lines, an average of 98 lines. In addition, only two patients presented 
the same surgical procedure: colostomy.  
c. PIPP:  
Ten subjects had a total of 478 PIPP scores collected. Out of this, following are the 
distributions for each PIPP scores: PIPP 0 = 15, PIPP 1 = 22, PIPP 2 = 38, PIPP 3 = 89, 
PIPP 4 = 84, PIPP 5 = 80, PIPP 6 = 52, PIPP 7 = 35, PIPP 8 = 25, PIPP 9 = 18, PIPP 10 = 
6, PIPP 11 =5, PIPP 12=5, PIPP 14=4. These scores were not regularly collected but are 
rather collected at different intervals, posing a challenge, as the PIPP scores were not 
continuous for every hour. PIPP scores were missing for 1651 out of a total of 2400 hours 
that were analyzed for the ten subjects. For this reason, only 749 hours of data could be 
used for analysis. 
5.1 Case Study 
For the preliminary analysis, the data was analysed as a case study for subject 1. A total of 1910 
hours of data were analysed for subject 1. For comparison purposes, the data for both scores for 
the subject were inputted into a pivot table, which was later plotted on a line graph. The data was 
filtered to exclude null values (blank) that were present within the PIPP data for an accurate 































































































































After the analysis, subject 1 was found to have greater PIPP scores then the APIPP scores. The 
PIPP maximum score is 21 and APIPP maximum score is 9; as such, investigating the difference 
between the two scores is imperative in order to understand the potential clinical efficacy. The 
following steps were carried out to create a data model: 
1. The difference between APIPP and PIPP score was computed in Excel for all values 
except null. Following this, four categories were created to analyse the difference between 
these two scores: 
Greater = PIPP score is greater than APIPP score 
Lesser = PIPP score is less than APIPP score 
Equal = PIPP score and APIPP score have a similar score 
Null= PIPP score was not collected when APIPP score was present 
2. Another column was created to display whether the PIPP score was greater, lesser, equal 







                      
              
3. Following this, a pivot table was created to compare the percentage difference for each of 
the four categories. Results were summarized in a table and displayed in graphical form. 
Following result was outputted: 




PIPP vs. Artemis 
2 8 6 Greater 
4   Null 
5 5 0 Equal 
5   Null 
2   Null 
2   Null 







































The results showed a higher percentage of null values (79.95%). Such a result demonstrates that 
among 79.95% of the hours that the infant was in the NICU, pain scores were not recorded on an 
hourly basis. This result shows that 79.95% of the time, the PIPP values were not collected or 
available when the APIPP values were. Since the APIPP score was consistently scored for every 
hour, these scores produced a more frequent result in comparison to the PIPP score, while the 
PIPP scores that were collected by the nurses at The Hospital for Sick Children, Toronto, Canada 
were collected in an intermittent manner. The data analysed showed that these values were not 




The second highest percentage was of the greater category. For 14.76% of the time, the PIPP 
score was greater than the APIPP score. This result was predictable as the PIPP scoring is a 21-
point scale whereas the APIPP is a 9-point scale. However, understanding the degree of 
difference between the PIPP score and APIPP score is important. Table 13 shows the differences 
that were recorded for each of the four categories.                           
Table	13.	List	of	#	of	times	a	difference	was	recorded	in	each	of	the	four	categories	(Subject	1)	
 
           
In total, 1910 hours of data were analysed for subject 1. In 66 instances, the PIPP score was less 
than APIPP score. In 35 instances, the PIPP score was equal to APIPP score.  In 282 instances, 
the PIPP score was greater than APIPP score.  For 1527 hourly instances of the APIPP score, the 
PIPP score was not recorded.  



















Grand Total 1910 
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To better understand and analyse the difference between APIPP and PIPP, the hours where a 
PIPP score was not recorded were removed. Within this context, for 73.63% of the hours studied, 
the PIPP was greater than APIPP. This states that if lesser, equal and greater categories were 
compared, for subject 1, for 73.63% of the time the PIPP score was greater than the APIPP score. 
It is also noteworthy to discover that for 17.23% of time the PIPP score was found to be lower 






Despite a 12-point difference between the two scales, it is important to investigate the lesser 
category findings as the generation of higher scores by the APIPP scale is a significant finding 
that requires further investigation. Various reasons can be associated with such a result. For 
example, because the automated scoring of APIPP provides an output based on physiological 
changes, the APIPP score may be more sensitive than the PIPP score. Because the APIPP score 
incorporates scoring of physiological changes with per second data into hourly chunks, the 
automated scoring of APIPP may have detected signs that were missed by the nurses’ PIPP 
scoring. Such a finding will be important to investigate in the future. Figure 4 shows the 
difference for the lesser, equal and greater categories. 










































































While analysing the greater category of differences, the difference between the PIPP and APIPP 
score was minimal. As Figure 5 shows, the PIPP score is not greater by a colossal number; the 
highest occurring difference is a difference of 2. Furthermore, the most occurring differences are 
between the range of 1-4. The difference of 1-4 is made up of 73% of the data, whereas, the 
remaining 5-11 difference only makes up 26%. It is important to conclude that most of the hours 
analysed, only reported a difference in the lower range of 1-4 when compared between PIPP and 
APIPP. In a 12-point difference between two scales, a difference of 1-4 does not account for a 
significant difference.  
5.2 Evaluation of Artemis Premature Infant Pain Profile (APIPP) 
Data Model 
Testing the APIPP model on a larger cohort of subjects is important in order to evaluate the 
model. After closely inspecting the data for case study analysis, 13 out of the 23 subjects were 
excluded due to insufficient data.  
The exclusion was mainly due to discontinuous data. Since the data was collected for 
every hour, it was important to have continuous data for accurate analysis purposes. Thirteen 
subjects had multiple hours missing throughout the data set, which could have led to inaccurate 
results. Overall, following exclusion, a total of 2400 hours were analysed, 240 ± 558.5 hours for 
ten patients. Data are presented as mean ± SD. Table 14 shows the percentage of missing data in 




Subjects with continuous hourly data were considered for analysis. After exclusion, ten subjects: 
six males and four females, where gestational age was 34 ± 4.8 weeks and birth weight was 2364 
± 870.5 grams, were considered for analysis.	Data are presented as mean ± SD. Table 15 shows 
the background information for ten subjects used in this experiment including gestational age 
(GA), birth weight (BW) in grams, sex of the subject, year of admission; admission diagnosis 
and the type of surgery performed if any. 
Subject 1 09/03/2010 20:00 11/03/2010 22:00 0%
Subject 2 08/05/2010 1:00 08/05/2010 12:00 0%
Subject X1 06/06/2010 20:00 07/06/2010 18:00 08/06/2010 3:00 09/06/2010 19:00 11%
Subject 3 31/10/2010 22:00 08/11/2010 7:00 0%
Subject 4 17/12/2010 8:00 18/12/2010 16:00 0%
Subject X2 Missing data at multiple points 9%
Subject X3 Missing data at multiple points 24%
Subject X4 Missing data at multiple points 26%
Subject 5 03/08/2011 23:00 05/08/2011 5:00 0%
Subject 6 10/10/2011 0:00 10/10/2011 23:00 0%
Subject 7 13/10/2011 22:00 17/10/2011 7:00 0%
Subject X5 Missing data at multiple points 73%
Subject X6 02/05/2013 16:00 02/05/2013 22:00 03/05/2013 10:00 05/05/2013 0:00 14%
Subject 8 14/05/2013 21:00 16/05/2013 10:00 0%
Subject X7 Missing data at multiple points 16%
Subject X8 17/05/2013 22:00 17/05/2013 22:00 18/05/2013 2:00 18/05/2013 8:00 27%
Subject X9 Missing data at multiple points 5%
Subject 9 19/05/2013 10:00 22/05/2013 9:00 0%
Subject X10 13/06/2013 21:00 19/06/2013 14:00 1%
Subject X11 Missing data at multiple points 3%
Subject 10 31/05/2013 22:00 02/06/2013 2:00 0%
Subject X12 08/06/2013 12:00 09/06/2013 0:00 09/06/2013 7:00 09/06/2013 7:00 30%
Subject X13 Missing data at multiple points 53%
Subj_No DataMissing[%]




Following the analysis for Subject 1, a similar analysis was conducted with ten subjects to 
evaluate the APIPP data model. Similar to subject 1 analysis, the difference between the two 
scores were investigated. Table 16 shows the data for all 10 subjects for all four categories.  
Table	16.	Ten	subject's	data	for	four	difference	categories	
 Lesser (%) Equal (%) Greater (%) Null (%) 
Subject 1 3.46 1.83 14.76 79.95 
Subject 2 9.09 9.09 9.09 72.73 
Subject 3 1.69 1.13 11.30 85.88 
Subject 4 6.25 3.13 15.63 75.00 
Subject 5 6.67 3.33 23.33 66.67 
Subject 6 0 4.17 4.17 91.67 
Subject 7 2.47 0 12.35 85.19 
Subject 8 5.41 5.41 2.70 86.49 
Subject 9 1.43 4.29 25.71 68.57 
Subject 10 3.57 3.57 21.43 71.43 
     
AVG 4.00 3.60 14.05 78.36 
STDEV 2.66 2.38 7.36 8.20 
    
Similar results as subject 1 analysis were found after evaluating the data. For 78.36% ± 8.2 of the 
time, the PIPP score was not available to be analysed while the APIPP score was available. For 
14.05% ± 7.4 of the time, the PIPP score was higher than the APIPP score. For 4% ± 2.7 of the 
time, the PIPP score was less than the APIPP score. Lastly, for 3.60% ± 2.4 of the time, the PIPP 
Subject ID GA BW (g) Sex Year Admission Diagnosis Comments Surg
Subject 1 28 680 M 2010 TEF/OA VAP [March 30, May 2] 1
Subject 2 35 2620 F 2010 Late preterm, gastrochisis, ileal atresia Repair, resection [May 5] 1
Subject 3 36 2690 M 2010 Hypoxic-ischaemic encephalopathy Therapeutic hypothermia, no surgery 0
Subject 4 31 2655 F 2010 Prematurity, posthaemorrhagic hydrocephalus VP sunt insertion [December 16] 1
Subject 5 24 700 F 2011 Haemodynamically significant ductus arteriosus PDA ligation [August 3] 1
Subject 6 40 3285 F 2011 Anorectal malformation Colostomy [October 9] 1
Subject 7 36 3100 M 2011 Trisomy 21, ASD, VSD, PPHN No surgery 0
Subject 8 39 2900 M 2013 TTN, PPHN No surgery 0
Subject 9 38 2500 M 2013 Anorectal malformation, hypospadias Colostomy [May 19] 1
Subject 10 33 2510 M 2013 Posterior urethral valves Valve ablation [May 31] 1
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score was equal to the APIPP score. Data are presented as mean ± SD. The results presented a 




Difference Category Subject 1 10 subjects (Avg) 
Null 79.95% 78.36% 
Greater 14.74% 14.05% 
Lesser  3.46% 4.00% 
Equal 1.83% 3.60% 
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Additionally, it was important to exclude the null (blank) data and analyse the subjects based on 


















             
These results propose a similar pattern to that of subject 1, where the PIPP score was greater than 
the APIPP score for majority of the hours. Of 62.96% ± 20.6 of the study population, the PIPP 
score is greater. For 18.13% ± 11.6 of the population, the PIPP score is less than APIPP. Lastly, 
for 18.91% ± 15.4 of the population, the PIPP score is equal to APIPP. Data are presented as 
mean ± SD. Figure 7 displays the data for each subject based on these three categories. 
  Greater (%) Lesser (%) Equal (%) 
Subject 1 73.63 17.23 9.14 
Subject 2 33.33 33.33 33.33 
Subject 3 80.00 12.00 8.00 
Subject 4 62.50 25.00 12.50 
Subject 5 70.00 20.00 10.00 
Subject 6 50.00 0.00 50.00 
Subject 7 83.33 16.67 0.00 
Subject 8 20.00 40.00 40.00 
Subject 9 81.82 4.55 13.64 
Subject 10 75.00 12.50 12.50 
        
AVG 62.96 18.13 18.91 
STDEV 20.64 11.60 15.43 
Difference Category Subject 1 10 Subjects (Avg) 
Greater 73.63% 62.96% 
Lesser 17.23% 18.13% 
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Frequency of Greater Difference for Subjects 1-10
Once again, analysing the greater differences between PIPP and APIPP scores for all 10 subjects 
was imperative. Table 20 displays the sum of times each difference occurred across all 10 
subjects in the greater category. 
Table	20.	Sum	of	times	each	greater	difference	occurred	for	subjects	1-10	
Difference S 1 S 2 S 3 S 4 S 5 S 6 S 7 S 8 S 9 S 10 TOTAL 
1 36 1 7 1     1   1 1 48 
2 63   3 2 2   3   1 4 78 
3 56   4 2 3 1 1   5   72 
4 52   4         1 5   62 
5 24   2   1   3   3 1 34 
6 24           2   2   28 
7 11       1       1   13 
8 6                   6 
9 3                   3 
10 2                   2 
11 5                   5 
 
As can be seen by Table 20 and Figure 8, the data for subject 1-10 presents a similar result to 
that of subject 1 alone. Similar to subject 1, subjects 1- 10 have a high frequency of times 
occurring differences in the lower range of 1-4. Similar to subject 1, the most occurring 
differences are two and three. The greater occurring differences are mostly below the difference 
of six. 
 
   














































Frequency of Greater Difference Excluding Subject 1
In this case, it was important to note the number of hours analyzed for each subject as this can 
have a great impact on the results. A total of 2400 hours were analysed for 10 subjects. The 
average for this population was 240 hours and the standard deviation was 558. hours. The 
standard deviation is very large, indicating that the number of hours between these subjects is 
very spread out. Since Subject 1 had a large number of hours (1910) for which data was 
available, analyzing the data without subject 1 is important. After excluding subject 1 from the 
dataset, the total number of hours analyzed was 490. The average number of hours for this 
population of 9 subjects was 54.4 hours and the standard deviation was 48.17 hours. In this case, 
since the standard deviation is closer to the mean, the number of hours analysed for all 9 subjects 
were closer to the mean.  
The data for 9 subjects was analyzed and graphed. Figure 9 displays the results for the frequency 
of differences without subject 1. Once again, the most occurring differences were those on the 
lower side, with the difference of three being the highest occurring difference with a total of 













Overall, in this chapter, APIPP was calculated and compared to PIPP in order to reflect on the 
potential efficacy of the APIPP model. Following this, the model was evaluated to examine how 
the APIPP compared to the already established scoring system of PIPP. The model was 
evaluated by conducting an analysis on both the scores to compare if the PIPP score was greater, 
lesser or equal to that of APIPP.  
 This analysis was first computed on subject 1 as a case study. Following this, for the 
purposes of evaluating the model, 10 subjects’ data was also analyzed by implicating similar 
analysis on this subset of subjects to assess the model. Both analysis presented similar results, 
where majority of hours were presented as null (blank) for PIPP scores when APIPP score was 
present. Such results showed that the PIPP score was not collected for the majority of the time 
during which the APIPP score was available and scored. These null values were excluded and 
only the available values for PIPP were compared to APIPP score for a more reliable 
comparison. Additionally, for the majority of the time, the PIPP score was found to be greater 
than the APIPP score. Such a finding was expected as the PIPP score was scored out of 21 
whereas the APIPP score was scored out of 9. For this reason, computing the difference between 
the two scores was important. On average, for both analyses, the difference between scores was 
less than six with a difference of two and three being more prominent in both analyses. Such 
differences between the two scores were negligible. Such a finding is noteworthy as PIPP 
scoring has a much higher score compared to the APIPP score. Such an analysis shows that the 
PIPP score must be highly scored based on physiological parameters as the difference between 
the two scores is minimal despite the difference between them. Conducting future research to 
investigate these findings is important. Chapter 6 presents a discussion from the clinical 
perspective in the context of the literature review preformed and presented in chapter 2. Chapter 
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6 will discuss the clinical side of using physiological parameters as indicators for pain. Since 
heart rate is the most commonly used physiological indicator, heart rate will be used for clinical 


















Chapter 6 - Physiological Data Analysis 
Following the case study and evaluation of data model in chapter 5, the relationship between 
physiological parameter (heart rate) and clinical data such as gestational age, admission 
diagnosis and surgery, will be explored in this chapter. This chapter attempts to investigate the 
clinical aspect of pain management. Heart rate will be used as a base physiological parameter as 
heart rate is widely used in the clinical field.  Heart rate will be analyzed in accordance with 
various other clinical indicators and PIPP scale to explore it as a reliable measure for designing a 
computational automatic score in the future to quantify pain in the premature infant. By 
exploring this clinical aspect through various experiments, such an analysis will provide an 
overview to create objective tools to measure pain in the neonatal population in the future. 
Additionally, this analysis will help in the assessment as well as management of pain relief, 
avoiding the consequences that occur due to untreated pain.  
Similar to chapter 5, the data of ten subjects was used to conduct the experiments in this 
chapter. The subjects’ consisted of six males and four females, whose mean gestational age was 
34 ± 4.8 weeks and mean birth weight was 2364 ± 870.5 grams.	Data are presented as mean ± 
SD. Table 21 outlines the background information for each patient, including gestational age 
(GA), sex of the subject, year of admission; admission diagnosis and the type of surgery 





6.1 Statistics  
For statistical analysis within the heart rate domain, heart rate of ten subjects was plotted based 
on three different categories on three different graphs for heart rate average, maximum and 
minimum using Graphpad Prism®. For each subject, an average was computed within the hourly 
data set of each subject. After this, each average for the three categories was plotted on a graph 
for all ten subjects. The graph displays the heart rate average for each subject and their standard 
deviation. Figure 10, 11 and 12 displays the results for heart rate average, maximum and 







Subject ID GA BW (g) Sex Year Admission Diagnosis Comments Surg
Subject 1 28 680 M 2010 TEF/OA VAP [March 30, May 2] 1
Subject 2 35 2620 F 2010 Late preterm, gastrochisis, ileal atresia Repair, resection [May 5] 1
Subject 3 36 2690 M 2010 Hypoxic-ischaemic encephalopathy Therapeutic hypothermia, no surgery 0
Subject 4 31 2655 F 2010 Prematurity, posthaemorrhagic hydrocephalus VP sunt insertion [December 16] 1
Subject 5 24 700 F 2011 Haemodynamically significant ductus arteriosus PDA ligation [August 3] 1
Subject 6 40 3285 F 2011 Anorectal malformation Colostomy [October 9] 1
Subject 7 36 3100 M 2011 Trisomy 21, ASD, VSD, PPHN No surgery 0
Subject 8 39 2900 M 2013 TTN, PPHN No surgery 0
Subject 9 38 2500 M 2013 Anorectal malformation, hypospadias Colostomy [May 19] 1













   
After analysing the heart rate average for ten patients, the non-surgical patients were found to 
have lower mean heart rate compared to the subjects who had surgery and presented with a 
severe admission diagnosis. As seen in Figure 10, Subject 3, 6, 7 and 8 are in the lower heart rate 
range. Three out of four of these subjects did not undergo surgery and hence have a lower heart 
rate average. Subject 6 was the only subject to have a surgery (colostomy) in this group. This 
subject is also the oldest subject in this data set, who is 40 weeks of gestational age. The 
subject’s gestational age may be associated with the heart rate being lower despite the subject 
having a previous surgery. Subjects 1, 2, 4, 5, 9 and 10 underwent surgeries, and therefore their 
heart rate is within the higher range, as the heart rate is over 130. Subject 5, who had an 
admission diagnosis of significant ductus arteriosus and had a corresponding PDA ligation 
surgery, shows the highest heart rate. Subject 5 was one of the subjects with serious 
Figure	10.	Heart	Rate	Average	data	for	subjects	1-10	
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comorbidities that required an intensive surgery. In addition, Subject 5 was also extremely 
preterm with a gestational age of 24, which is the lowest in this group. Such findings show a 
pattern between heart rate, gestational age, surgical procedures and illness.  This pattern of heart 



















Figure 11 displays the results for maximum heart rate of the 10 subjects. This figure depicts a 
similar result to the figure for heart rate average. However, compared to the average heart rate 
data, the heart rate maximum data is more consistent. Once again, subjects 3, 6, 7 and 8 have a 
lower maximum heart rate, where most subjects have a heart rate of under 140. Among the four 
subjects, three subjects did not have a surgery, while subject 6, who is the oldest subject, had a 
Figure	11.	Maximum	Heart	Rate	Data	for	Subjects	1-10 
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surgery. Hence the heart rates of these four subjects were not very elevated in comparison to the 
other subjects. Subjects 1, 2, 4, 5, 9, and 10 are displaying a much higher maximum heart rate, 
with most subjects having a heart rate of more than 170. A consistent trend is observed with the 
maximum heart rate data, which displays maximum heart rate of 170 for most of the subjects. As 


















Figure 12 displays the results for minimum heart rate. Most of the subjects have a fairly similar 
minimum heart rate. However, subject 5 shows a much higher minimum heart rate compared to 
other subjects. Subject 5 is also the youngest and most premature neonate with a gestational age 
of 24 who underwent a serious surgery (PDA ligation) for a serious comorbidity of significant 
Figure	12.	Minimum	Heart	Rate	Data	for	Subjects	1-10 
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ductus arteriosus. In common clinical practice, the nurses monitor the heart rate in a manner 
where heart rate does not decline to an anomalistic rate as such a heart rate can hinder the 
stability of the neonate, which is reflected in the minimum heart rate data presented in Figure 12. 
Figure 12 shows that the minimum heart rate is similar for most subjects.  Thus, the minimum 
heart rate is shown to be a less useful marker for assessing pain.  
6.2 ANOVA  
In this experiment, a one-way analysis of variance ANOVA was used to determine if any 
significant differences existed between the heart rate average, minimum and maximum among 
the ten subjects. One may assume that heart rate does differ from individual to individual; 
however patterns can be observed for resting, normal and exercising, which in turn can help to 
establish heart rate patterns for healthy individuals. Similarly, this test aims to explore the 
hypothesis that a pattern exists among premature infants based on gestational age, illness or pain. 
This test was also used to determine whether any significant differences exist between the means 
of three or more patients.   
Population: Ten subjects. One-way ANOVA was performed using Microsoft Excel®. 
Specifically, this test tests the null hypothesis, which states that there are no differences between 
the means of this group of subjects. If the null hypothesis is rejected, the alternative hypothesis is 
accepted, which would show that at least two subjects are significantly different from each other.  
After conducting the one-way ANOVA test with heart rate averages, a statistically significant 
difference was found between groups as determined (F (9, 531) = 220.33, p = 6.13E-173). Table 




SUMMARY   
Groups Count Sum Average Variance   
Subject 1 51 7183 140.85 28.722   
Subject 2 11 1412 128.36 46.486   
Subject 3 177 18979 107.23 108.571   
Subject 4 32 4776 149.25 68.252   
Subject 5 30 4838 161.28 38.021   
Subject 6 24 2772 115.51 32.072   
Subject 7 81 9806 121.06 75.933   
Subject 8 37 4301 116.24 132.911   
Subject 9 70 10365 148.07 188.908   
Subject 10 28 4190 149.64 33.423   
ANOVA 	  
Source of 
Variation SS df MS F P-value F crit 
Between 
Groups 185835.8 9 20648.43 220.3351 6.13E-173 1.897504 
Within Groups 49762 531 93.71375       
Total 235597.8 540         
 
After conducting the one-way ANOVA test with heart rate maximum, a statistically significant 
difference was found between groups (F (9, 531) = 131.1, p = 8.80E-129). The results are 
presented in Table 23. 
Table	23.	ANOVA	heart	rate	maximum	
SUMMARY       
Groups Count Sum Average Variance   
Subject 1 51 8696 170.51 188.495   
Subject 2 11 1877 170.64 191.255   
Subject 3 177 22506 127.15 335.891   
Subject 4 32 5489 171.53 181.289   
Subject 5 30 5188 172.93 84.478   
Subject 6 24 3306 137.75 31.065   
Subject 7 81 11135 137.47 97.302   
Subject 8 37 5064 136.86 130.342   
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Subject 9 70 12030 171.86 92.559   
Subject 10 28 4979 177.82 125.041   
ANOVA       
Source of 
Variation SS df MS F P-value F crit 
Between Groups 225532.89 9 25059.21 131.1268 8.80E-129 1.897504 
Within Groups 101477.68 531 191.11 		 		 		
Total 327010.58 540 		 		 		 		
 
After conducting the one-way ANOVA test with heart rate minimum, a statistically significant 
difference was found between groups as determined by one-way ANOVA (F (9, 531) = 120.7, p 
= 4.61E-30). The results are presented in Table 24.  
Table	24.	ANOVA	heart	rate	minimum	
SUMMARY       
Groups Count Sum Average Variance   
Subject 1 51 5486 107.57 338.53   
Subject 2 11 1106 100.55 202.473   
Subject 3 177 16307 92.13 335.455   
Subject 4 32 3120 97.5 643.677   
Subject 5 30 4056 135.2 210.786   
Subject 6 24 2243 93.46 137.824   
Subject 7 81 8795 108.58 208.697   
Subject 8 37 3186 86.11 1183.21   
Subject 9 70 8037 114.81 1064.588   
Subject 10 28 3320 118.57 164.995   
ANOVA       
Source of Variation SS df MS F P-value F crit 
Between Groups 85933.96 9 9548.22 20.74249 4.61E-30 1.897504 
Within Groups 244430.75 531 460.32       
Total 330364.7 540         
 
The results for each of the three categories (average HR, maximum HR, and minimum HR) show 
that a significant difference exists. Although a one-way ANOVA can indicate that a significant 
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difference exists between two groups, this test is unable to specify which specific groups were 
significantly different from each other. To determine which specific groups differed from each 
other, the Tukey Kramer test was conducted. This test is performed following an analysis of 
variance (ANOVA) test.  
6.3 Tukey Kramer Test 
Following the one-way ANOVA, the Tukey Kramer test was performed as the one-way ANOVA 
test for all three experiments showed that there are significant differences between subjects.  The 
purpose of Tukey Kramer test is to determine which groups in the sample differ. This test 
compares all possible pairs of means and is based on a studentised range distribution (q). If the 
results of ANOVA are positive (i.e. a significant difference is shown among groups), a Tukey 
Kramer test can be performed. It is not likely that all groups differ when compared to each other, 
but that only some have significant differences. The Tukey Kramer test helps to clarify which 
specific groups among the sample have significant differences.  This test revealed where the 
significant differences were between these subjects. Three different Tukey Kramer test were 
manually preformed in Microsoft Excel® with the data for ten subjects based on heart rate 
average, minimum and maximum.  
To compute the Tukey test, the critical value is very important. The critical value is used 
to evaluate whether differences between any two pairs of means are significant.  The critical 
value also involves the absolute difference that has to be exceeded to achieve significance. For 
this, all possible pairs of comparisons were listed. The # of comparisons are calculated through 
equation 5 (n= # of groups): 




In this experiment, forty-five comparisons were required to compute the test. After this, the 
absolute difference is calculated through equation 6 (x = mean):  
           /0123456	$ 	− 	/7123456	&        Equation 5 
Following this, the critical value was calculated using Equation 7.  For this, the q value was 
found through the critical values of the studentised range table with	  	0.05. MS value was taken 
from the ANOVA table. n represented the total # of observations for each subject. Since the data 
for all subjects were unequal, the lesser observations out of the two subjects were used. 
                                                         9 :7!                      Equation 6 
Lastly, if the absolute difference was larger than the critical value, the comparison was found to 
be significantly different. When the Tukey Kramer test was conducted for heart rate average, a 
total of 45 comparisons were outputted, of which 11 comparisons showed a non-significant result 
and 34 showed significantly different results. Table 25 presents the results. 
Table	25.	Tukey	Kramer	Test-	heart	rate	average	
Tukey Kramer Test for Average Heart Rate 
Comparison Absolute Difference Critical Range Results 
Subject 1 vs. Subject 2 12.49 13.0587 not significantly different 
Subject 1 vs. Subject 3 33.63 6.0647 significantly different 
Subject 1 vs. Subject 4 8.4 7.6564 significantly different 
Subject 1 vs. Subject 5 20.43 7.9075 significantly different 
Subject 1 vs. Subject 6 25.34 8.8408 significantly different 
Subject 1 vs. Subject 7 19.79 6.0647 significantly different 
Subject 1 vs. Subject 8 24.61 7.1203 significantly different 
Subject 1 vs. Subject 9 7.22 6.0647 significantly different 
Subject 1 vs. Subject 10 8.79 8.185 significantly different 
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Subject 2 vs. Subject 3 21.13 13.0587 significantly different 
Subject 2 vs. Subject 4 20.89 13.0587 significantly different 
Subject 2 vs. Subject 5 32.92 13.0587 significantly different 
Subject 2 vs. Subject 6 12.85 13.0587 not significantly different 
Subject 2 vs. Subject 7 7.3 13.0587 not significantly different 
Subject 2 vs. Subject 8 12.12 13.0587 not significantly different 
Subject 2 vs. Subject 9 19.71 13.0587 significantly different 
Subject 2 vs. Subject 10 21.28 13.0587 significantly different 
Subject 3 vs. Subject 4 42.02 7.6564 significantly different 
Subject 3 vs. Subject 5 54.05 7.9075 significantly different 
Subject 3 vs. Subject 6 8.29 8.8408 not significantly different 
Subject 3 vs. Subject 7 13.83 4.8123 significantly different 
Subject 3 vs. Subject 8 9.02 7.1203 significantly different 
Subject 3 vs. Subject 9 40.84 5.1766 significantly different 
Subject 3 vs. Subject 10 42.42 8.185 significantly different 
Subject 4 vs. Subject 5 12.03 7.9075 significantly different 
Subject 4 vs. Subject 6 33.74 8.8408 significantly different 
Subject 4 vs. Subject 7 28.19 7.6564 significantly different 
Subject 4 vs. Subject 8 33.01 7.6564 significantly different 
Subject 4 vs. Subject 9 1.18 7.6564 not significantly different 
Subject 4 vs. Subject 10 0.39 8.185 not significantly different 
Subject 5 vs. Subject 6 45.77 8.8408 significantly different 
Subject 5 vs. Subject 7 40.22 7.9075 significantly different 
Subject 5 vs. Subject 8 45.04 7.9075 significantly different 
Subject 5 vs. Subject 9 13.21 7.9075 significantly different 
Subject 5 vs. Subject 10 11.64 8.185 significantly different 
Subject 6 vs. Subject 7 5.55 8.8408 not significantly different 
Subject 6 vs. Subject 8 0.73 8.8408 not significantly different 
Subject 6 vs. Subject 9 32.56 8.8408 significantly different 
Subject 6 vs. Subject 10 34.13 8.8408 significantly different 
Subject 7 vs. Subject 8 4.82 7.1203 not significantly different 
Subject 7 vs. Subject 9 27.01 5.1766 significantly different 
Subject 7 vs. Subject 10 28.58 8.185 significantly different 
Subject 8 vs. Subject 9 31.83 7.1203 significantly different 
Subject 8 vs. Subject 10 33.4 8.185 significantly different 
Subject 9 vs. Subject 10 1.57 8.185 not significantly different 
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The results of Tukey Kramer Test for heart rate average showed eleven comparisons as ‘not 
significantly different’. Table 26 presents the results for the ‘not significantly different’ results. 
The results illustrate a similarity between the average heart rate of these subjects. Based on this 
evidence, the clinical record and notes of the subjects were further analysed to investigate the 
similarities and/or pattern.  
The clinical record of the subjects showed a similarity regarding the surgical procedures 
that were performed during their stay in the NICU. Seven pairs of subjects who underwent 
surgical procedures presented ‘not significantly different result’ out of which one group of 
subjects did not undergo any surgical procedure. The analysis found that the subjects who 
showed a ‘not significantly different’ result were the subjects who presented with a severe illness 
in their admission diagnosis.  
Table	26.	'Not	significantly	different'	subject	group	





Subject 1 vs. 
Subject 2 12.49 13.0587 
Not significantly 
different 1,1 
Subject 2 vs. 
Subject 6 12.85 13.0587 
Not significantly 
different 1,1 
Subject 2 vs. 
Subject 7 7.3 13.0587 
Not significantly 
different 1,0 
Subject 2 vs. 
Subject 8 12.12 13.0587 
Not significantly 
different 1,0 
Subject 3 vs. 
Subject 6 8.29 8.8408 
Not significantly 
different 0,1 
Subject 4 vs. 
Subject 9 1.18 7.6564 
Not significantly 
different 1,1 
Subject 4 vs. 
Subject 10 0.39 8.185 
Not significantly 
different 1,1 
Subject 6 vs. 
Subject 7 5.55 8.8408 
Not significantly 
different 1,0 
Subject 6 vs. 
Subject 8 0.73 8.8408 
Not significantly 
different 1,0 
Subject 7 vs. 




Subject 9 vs. 




a) 1,0: One patient with surgery and one without having underwent surgery 
The subject groups in this category involved a subject who had a surgery and the other 
who did not undergo surgery. However, after analysis, subjects who did not have surgery 
were found to have severe illnesses. As such, the subjects who did not have surgery 
presented similar results to those that did have surgery. There were five subject groups 
who were in this category. 
 Subject 2 vs. Subject 8: Subject 2 is a late preterm infant at 35 GA with admission 
diagnosis of gastrochisis and ileal atresia who had a repair and resection surgery. Subject 
8 was 39 GA who did not undergo surgery. However, his admission diagnosis was 
Transient Tachypnea of the Newborn (TTN) and Persistent Pulmonary Hypertension of 
the Newborn (PPHN).  Such a diagnosis suggests that the subject was very sick.  
 
Subject 2 vs. Subject 7: Subject 2 is a late preterm infant at 35 GA with admission 
diagnosis of gastrochisis and ileal atresia who had a repair and resection surgery. Subject 
7 was 36 GA who did not undergo surgery; however, his admission diagnosis illustrated 
severe sickness such as Trisomy 21, Atrial Septal Defect (ASD), Ventricular Septal 
Defect (VSD) and Persistent Pulmonary Hypertension of the Newborn (PPHN). 
 
Subject 3 vs. subject 6: Subject 3 is a late preterm infant at 36 GA who did not undergo 
surgery; however, the subject presented with hypoxic-ischaemic encephalopathy (HIE), 
which is a severe illness where the infant’s brain does not receive enough oxygen and 
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blood. Studies have found that patients with HIE present lower heart rate variability 
compared to healthy infants. Subject 6, on the other hand, did have a colostomy surgery. 
 
Subject 6 vs. subject 7: Subject 6 was a term infant at 40 GA who had a colostomy 
surgery. Subject 7 was a moderate to late preterm infant at 36 GA who did not undergo 
surgery; however, his admission diagnosis indicated severe comorbidities including 
Trisomy 21, Atrial Septal Defect (ASD), Ventricular Septal Defect (VSD) and Persistent 
Pulmonary Hypertension of the Newborn (PPHN). 
 
Subject 6 vs. subject 8: Subject 6 was a term infant at 40 GA who had a colostomy 
surgery. Subject 8 was also a term infant at 39 GA who did not undergo surgery. 
However, his admission diagnosis was Transient Tachypnea of the Newborn (TTN) and 
Persistent Pulmonary Hypertension of the Newborn (PPHN).  This is suggestive of severe 
illness.   
b) 1,1: Both subjects with surgery 
The subject groups involved in this category all had surgeries; due to this they outputted a 
‘not significantly different result’ amongst them. There were five subject groups involved 
in this category that include: Subject 1 vs. subject 2; Subject 2 vs. Subject 6; Subject 4 vs. 
subject 9; Subject 4 vs. subject 10; Subject 9 vs. subject 10.  
c) 0,0: No subjects with surgery 
Subject 7 vs. subject 8: Even though both these subjects did not have surgery, they were 
both significantly sick compared to other subjects. Subject 7 was 36 GA who did not 
undergo surgery; however, his admission diagnosis showed severe comorbidities such as 
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Trisomy 21, Atrial Septal Defect (ASD), Ventricular Septal Defect (VSD) and Persistent 
Pulmonary Hypertension of the Newborn (PPHN). Subject 8 was 39 GA with an 
admission diagnosis of Transient Tachypnea of Newborn (TTN) and Persistent 
Pulmonary Hypertension of the Newborn (PPHN). Both subjects had PPHN, which could 
be a potential reason as to why differences between the subjects were not significant.  
 
In conclusion, the heart rate average Tukey test shows that surgery, severity of illness, and 
gestational age are factors that can contribute to a similar pattern of heart rate. This analysis 
shows that the subjects with serious comorbidities are similar in their heart rate averages and 
therefore show a ‘not significantly different’ result between them. Severity of illness has been 
explored as an influence on pain scores among preterm infants in many studies (Johnston et al., 
1999; Stevens et al., 1999; Stevens, Johnston, & Horton, 1994).  
Table	27.	Tukey	Kramer	Test-	maximum	heart	rate	
Tukey Kramer Procedure for Maximum Heart Rate 
Comparison Absolute Difference Critical Range Results 
Subject 1 vs. Subject 2 0.13 18.6482 not significantly different 
Subject 1 vs. Subject 3 43.36 8.6606 significantly different 
Subject 1 vs. Subject 4 1.02 10.9335 not significantly different 
Subject 1 vs. Subject 5 2.42 11.2921 not significantly different 
Subject 1 vs. Subject 6 32.76 12.6249 significantly different 
Subject 1 vs. Subject 7 33.04 8.6606 significantly different 
Subject 1 vs. Subject 8 33.64 10.1679 significantly different 
Subject 1 vs. Subject 9 1.35 8.6606 not significantly different 
Subject 1 vs. Subject 10 7.31 11.6884 not significantly different 
Subject 2 vs. Subject 3 43.48 18.6482 significantly different 
Subject 2 vs. Subject 4 0.89 18.6482 not significantly different 
Subject 2 vs. Subject 5 2.3 18.6482 not significantly different 
Subject 2 vs. Subject 6 32.89 18.6482 significantly different 
Subject 2 vs. Subject 7 33.17 18.6482 significantly different 
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Subject 2 vs. Subject 8 33.77 18.6482 significantly different 
Subject 2 vs. Subject 9 1.22 18.6482 not significantly different 
Subject 2 vs. Subject 10 7.19 18.6482 not significantly different 
Subject 3 vs. Subject 4 44.38 10.9335 significantly different 
Subject 3 vs. Subject 5 45.78 11.2921 significantly different 
Subject 3 vs. Subject 6 10.6 12.6249 not significantly different 
Subject 3 vs. Subject 7 10.32 6.8721 significantly different 
Subject 3 vs. Subject 8 9.71 10.1679 not significantly different 
Subject 3 vs. Subject 9 44.7 7.3924 significantly different 
Subject 3 vs. Subject 10 50.67 11.6884 significantly different 
Subject 4 vs. Subject 5 1.4 11.2921 not significantly different 
Subject 4 vs. Subject 6 33.78 12.6249 significantly different 
Subject 4 vs. Subject 7 34.06 10.9335 significantly different 
Subject 4 vs. Subject 8 34.67 10.9335 significantly different 
Subject 4 vs. Subject 9 0.33 10.9335 not significantly different 
Subject 4 vs. Subject 10 6.29 11.6884 not significantly different 
Subject 5 vs. Subject 6 35.18 12.6249 significantly different 
Subject 5 vs. Subject 7 35.46 11.2921 significantly different 
Subject 5 vs. Subject 8 36.07 11.2921 significantly different 
Subject 5 vs. Subject 9 1.08 11.2921 not significantly different 
Subject 5 vs. Subject 10 4.89 11.6884 not significantly different 
Subject 6 vs. Subject 7 0.28 12.6249 not significantly different 
Subject 6 vs. Subject 8 0.89 12.6249 not significantly different 
Subject 6 vs. Subject 9 34.11 12.6249 significantly different 
Subject 6 vs. Subject 10 40.07 12.6249 significantly different 
Subject 7 vs. Subject 8 0.6 10.1679 not significantly different 
Subject 7 vs. Subject 9 34.39 7.3924 significantly different 
Subject 7 vs. Subject 10 40.35 11.6884 significantly different 
Subject 8 vs. Subject 9 34.99 10.1679 significantly different 
Subject 8 vs. Subject 10 40.96 11.6884 significantly different 
Subject 9 vs. Subject 10 5.96 11.6884 not significantly different 
 
Table 27 presents the results for the Tukey Kramer test performed for maximum heart rate. The 
maximum heart rate Tukey test showed 20 ‘not significantly different’ results and 25 
‘significantly different’ results out of the 45 different comparisons performed. The subject 
groups are both divided into almost equal sides with a difference of five.  
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Table	28.	Tukey	Kramer	test-	minimum	heart	rate	
Tukey Kramer Procedure for Minimum Heart Rate  
Comparison Absolute Difference Critical Range Results 
Subject 1 vs. Subject 2 7.02 28.9421 not significantly different 
Subject 1 vs. Subject 3 15.44 13.4413 significantly different 
Subject 1 vs. Subject 4 10.07 16.9688 not significantly different 
Subject 1 vs. Subject 5 27.63 17.5253 significantly different 
Subject 1 vs. Subject 6 14.11 19.5939 not significantly different 
Subject 1 vs. Subject 7 1.01 13.4413 not significantly different 
Subject 1 vs. Subject 8 21.46 15.7807 significantly different 
Subject 1 vs. Subject 9 7.25 13.4413 not significantly different 
Subject 1 vs. Subject 10 11 18.1404 not significantly different 
Subject 2 vs. Subject 3 8.42 28.9421 not significantly different 
Subject 2 vs. Subject 4 3.05 28.9421 not significantly different 
Subject 2 vs. Subject 5 34.65 28.9421 significantly different 
Subject 2 vs. Subject 6 7.09 28.9421 not significantly different 
Subject 2 vs. Subject 7 8.03 28.9421 not significantly different 
Subject 2 vs. Subject 8 14.44 28.9421 not significantly different 
Subject 2 vs. Subject 9 14.27 28.9421 not significantly different 
Subject 2 vs. Subject 10 18.03 28.9421 not significantly different 
Subject 3 vs. Subject 4 5.37 16.9688 not significantly different 
Subject 3 vs. Subject 5 43.07 17.5253 significantly different 
Subject 3 vs. Subject 6 1.33 19.5939 not significantly different 
Subject 3 vs. Subject 7 16.45 10.6656 significantly different 
Subject 3 vs. Subject 8 6.02 15.7807 not significantly different 
Subject 3 vs. Subject 9 22.68 11.473 significantly different 
Subject 3 vs. Subject 10 26.44 18.1404 significantly different 
Subject 4 vs. Subject 5 37.7 17.5253 significantly different 
Subject 4 vs. Subject 6 4.04 19.5939 not significantly different 
Subject 4 vs. Subject 7 11.08 16.9688 not significantly different 
Subject 4 vs. Subject 8 11.39 16.9688 not significantly different 
Subject 4 vs. Subject 9 17.31 16.9688 significantly different 
Subject 4 vs. Subject 10 21.07 18.1404 significantly different 
Subject 5 vs. Subject 6 41.74 19.5939 significantly different 
Subject 5 vs. Subject 7 26.62 17.5253 significantly different 
Subject 5 vs. Subject 8 49.09 17.5253 significantly different 
Subject 5 vs. Subject 9 20.39 17.5253 significantly different 
Subject 5 vs. Subject 10 16.63 18.1404 not significantly different 
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Subject 6 vs. Subject 7 15.12 19.5939 not significantly different 
Subject 6 vs. Subject 8 7.35 19.5939 not significantly different 
Subject 6 vs. Subject 9 21.36 19.5939 significantly different 
Subject 6 vs. Subject 10 25.11 19.5939 significantly different 
Subject 7 vs. Subject 8 22.47 15.7807 significantly different 
Subject 7 vs. Subject 9 6.23 11.473 not significantly different 
Subject 7 vs. Subject 10 9.99 18.1404 not significantly different 
Subject 8 vs. Subject 9 28.71 15.7807 significantly different 
Subject 8 vs. Subject 10 32.46 18.1404 significantly different 
Subject 9 vs. Subject 10 3.76 18.1404 not significantly different 
 
This Tukey test revealed 25 ‘not significantly different’ results and 20 ‘significantly different’ 
results out of the 45 different comparisons performed. In this case, there are more subject groups 
who outputted ‘not significantly different’ results compared to the subject groups who outputted 
‘significantly different’ results. This result may be indicative of the fact that most subjects 
presented a similar average minimum heart rate. Figure 12 previously showed that this result 
presented an average minimum heart rate of 105 beats/minute and a standard deviation of 14.3 
beats/minute. Additionally, this result showed that the minimum heart rates are similar to the 
mean of the 10 subjects. For this reason, the test outputted more ‘not significantly different’ 
result in comparison to those that were ‘significantly different’. This result further reiterates the 
fact that heart rate minimum is not a sensitive marker to be used for pain assessment.  
6.4 Curve Fitting 
The population of ten subjects were introduced to the Curve Fitting Toolbox, using 
Matlabworks®, fitting gestational age versus maximum, average and minimum heart rate data in 
this population. The goodness of fit of a statistical model describes how well the data fits a set of 
observations. The data was fitted to a regression polynomial linear model, Equation 8, to test if 
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the heart rate in this subset of patients was following a pattern that was dependent on gestational 
age. 
; / = <1 ∗ / + <2	  Equation 8 
Table	29.	Goodness	of	fits	
 
SSE, R-square and RMSE demonstrated that the regression line does not fit the data, thus the 
heart rate in this population is not following a particular pattern that was dependent on 

































The figures highlight the complex distribution of the heart rate data through the gestational age 
spectrum without presenting a consistent pattern. Since no apparent pattern was observed within 
the gestational age spectrum, clinical notes were analysed to look into the subjects’ surgery data. 
In this case, as the gestational age of 36 is showing a very low heart rate average as well as very 




age, did not have a surgery. Hence, it could be concluded that due to perhaps less pain or 
discomfort in this gestational age group, the heart rate was reported to be lower compared to 
other subjects. The regression line did not fit the data as every subject is unique and has different 
clinical implications. A particular premature infants heart rate is driven by what clinical context 
he/she are in.  
6.5 Surface model comparing PIPP vs. AVG HR vs. GA 
Utilizing Curve Fitting Toolbox in Matlabworks®, the population of ten subjects was plotted 
using biharmonic interpolation to scatter the data in the surface model, as shown in Figure 16. 
This analysis was performed to analyse and find the correlations between PIPP scores taken from 
Hospital for Sick Children, Toronto, Canada, the average heart rate data from The Artemis 








Figure 16 illustrates the PIPP scores in a very scattered pattern where a particular PIPP score is 
recorded for multiple heart rate values and GA. Thus, showing that specific criteria are not 
followed for heart rate and pain scoring. Based on this result, inconsistency is observed, as PIPP 
Figure	16.	Biharmonic	Interpolation	
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scores do not match consistently with heart rate thresholds. There can be many reasons for the 
inconsistent result. Nonetheless, designing a more reliable, accurate and consistent automated 
system of scoring is important in order to eliminate these problems and discrepancy in scoring.  
6.6 Conclusion 
In conclusion, the results presented in this chapter may help to better understand the heart rate 
indicator and its constantly changing complexity due to painful stimuli. It is evident from the 
results presented in this chapter that heart rate average can prove to be a useful measure in 
providing insight into detecting painful events. In contrast, through the statistical analysis 
completed (ANOVA, Tukey Kramer Test, and Curve Fitting), heart rate minimum is not found 
to be a useful marker since heart rate minimum presented a standard consistent pattern between 
all subjects as in clinical practice, heart rate is monitored carefully by health care professionals to 
ensure it does not go below the baseline standards set. Based on the overall analysis presented in 
this chapter, heart rate can be a useful marker when used in accordance with gestational age to 
classify pain in the premature infant. These results also reiterate the need for a pain assessment 
tool that adjusts for gestational age when scoring. The completed analysis showed a clear 
correlation between gestational age and heart rate. Premature infants baseline heart rate differs at 
varying gestational ages, which in turn, can affect their pain scores in a substantial way. 
Analysing continuous physiological data helped to identify and examine areas, which may have 
been missed with the manual collection of PIPP scores at inconsistent time points. Manual 
collection of physiological indicators at inconsistent time points loses information relevant to the 
neonates’ physiology. As such, the creation of an automated system using big data analytics is 
important for the collection of physiological changes and the accurate detection of pain by 
avoiding misreporting of pain.  
Chapter 7 - Discussion 
In this chapter, the findings of the evaluation of data model are discussed and how they are 
linked to the existing literature on pain management. Limited understanding on infant pain has 
led to its lack of recognition in clinical practice. As a result, there is still a lack of a gold standard 
per say for assessing pain in the neonatal population.  Many infants still don’t receive any pain 
treatment during commonly performed painful procedures (Cignacco et al., 2009; Harrison et al., 
2014; Johnston, Barrington, Taddio, Carbajal, & Filion, 2011). These studies highlight an 
important knowledge to practice gap, which can negatively impact the health of newborn infants. 
In the past, a common presumption was that neonatal infants were not capable of fully perceiving 
pain. However, such a claim was contradicted by evidence from subsequent studies. For 
example, a recent study by Goksan et al. incorporated an fMRI to study newborn infant pain. The 
fMRI identified a network of brain regions that are active following acute noxious stimulation in 
newborn infants, where such activity was compared to that observed in adults. After analyzing 
this, the study discovered significant infant brain activity in 18 of the 20 active adult brain 
regions (Goksan et al., 2015). Brain regions that encode sensory and affective components of 
pain are active in infants, suggesting that the infant pain experience closely resembles that seen 
in adults (Goksan et al., 2015). These findings and the ones outlined in this thesis highlight the 
importance of developing effective and reliable pain assessment tools in this vulnerable 
population. Hence, an attempt was made in this thesis to design a clinical DSS model for 
automated partial PIPP scoring based on the elements that can be determined without the need 
for clinical observation. The clinical DSS was designed depicting the current standard of pain 




The evaluation of the data model presented noteworthy results where one of the 
important finding was that the PIPP score was not scored each hour APIPP was scored, and on 
average, PIPP was only scored 20% of the hours within this study. Such an issue outlines the 
limitation of the manual scoring systems being used at hospitals. The analysis completed in this 
thesis between the two scales also explored the difference between the two scales since the PIPP 
was scored out of 21 and the APIPP was scored out of 9 points. There was a 12-point difference 
between these two scales. For the case study on subject 1, the PIPP score was not available when 
the APIPP was available for 79.95% of the time. A similar result was found for the analysis done 
with 10 subjects, where the PIPP score was not available when the APIPP was available for 
78.36% of the time. Such a finding is significant, as the PIPP data could not be compared with 
the hourly APIPP score for nearly 80% of the time. Such a result suggests that the nurses did not 
score the PIPP consistently as many hours of data were missing. This is worrisome as significant 
changes in the premature infant’s physiology can take place during the hours in which the PIPP 
is not scored. The second highest percentage was found for the greater category. Specifically, for 
case study for subject 1, PIPP score was greater than the APIPP score for 14.76% of the time. 
Similarly, for the data analysis with the 10 subjects, PIPP score was greater than the APIPP score 
for 14.05% of the time. Such a result was expected as PIPP score is scored out of a higher value 
in comparison to APIPP. Thus, the percent difference between the two scales was explored. For 
both analyses, high frequency of occurring differences were in the lower range with most 
differences ranging between one and four. More specifically, a difference of two and three had 
the highest occurrence for both analyses. This was concluded to be a non-significant difference 
acknowledging the fact that there was a 12-point difference between the two scales. This is a 
significant finding as PIPP is scored out of a much higher number (21) compared to APIPP (9). 
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The highest frequency of differences being two or three concludes that APIPP score was fairly 
similar to the PIPP score that was scored by the nurses. It can be inferred from this finding that 
perhaps the PIPP score tends to be highly based on the physiological changes and GA, which the 
APIPP was constructed of. In this case, it can also be inferred that perhaps the nurses were not 
able to score the various behavioural parameters due to sedation or inactivity in the infant due to 
prematurity. Additionally, it could also be speculated that perhaps APIPP score was more 
sensitive as it consisted of per second physiological data, which the PIPP perhaps missed. It is 
important to further investigate these findings. To further investigate these findings, a 
physiological analysis using HR data was conducted in chapter 6. Chapter 6 presented various 
experiments that presented a clinical perspective on pain management. The results presented in 
chapter 6 helped in understanding the complexity of the heart rate indicator and its 
resourcefulness as a marker for pain detection. These results indicate the importance of 
incorporating a clinical context within pain assessment tools. Factors such as GA, severity of 
illness and severity of surgery can present fluctuating changes within heart rate. The experiments 
discussed in this thesis are preliminary in nature and were run in DB2. Executing these 
experiments in InfoSphere streams is possible. In the future, this concept can be implemented in 
real-time in streams to run every hour and produce a pain score that could assist physicians and 
nurses. It is important to carry out prospective research to experiment with real-time stream 
processing to integrate a scale such as APIPP. An exploratory approach presented in this thesis 
helps to recognize the need and the resourcefulness of designing an automated pain scoring 
system using a platform such as Artemis, which provides real-time physiological data. A stand-
alone automated system can be designed based on this work, which will provide continuous 
monitoring of pain in the NICU with the contextual support of the physicians and nurses.  
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The various different pain management systems described in chapter 2 can be used as 
background knowledge to implement a well-rounded, reliable pain management system. The 
richness of information can be extrapolated from the neonatal information sources in the form of 
concepts and categories, and these concepts and categories can be used to understand the context 
of neonatal pain management, and finally interconnect the concepts and categories as an 
ontology to severe pain management. One of the main areas that has been extensively 
implemented in the neonatal population is facial recognition systems. Recent research has 
provided evidence of the usefulness of facial cues for automatic pain analysis; however, such 
research has mainly focused on detection of presence/absence of pain. Such facial cues can 
become inadequate during circumstances where a neonate is recovering from surgery, or is 
highly sedated and premature to provide facial cues. For this reason, such systems should be 
integrated into more objective-based systems that can provide reliable results despite these 
hurdles. Computer-aided decision support offers help, but the existing systems are not user-
friendly or do not support an on-line application from clinical documentation. Thus, these 
applications are not available in everyday clinical practice for health care providers to use (Eich 
et al., 1997). The pain detection system should be designed so that the system is at the central 
point-of care where the clinicians have easy accessibility.  
Currently, one central problem is the fact that a simple method is not available for the 
direct measurement of pain. In most cases of pain assessment, the examining physician must rely 
on the patient’s qualitative description about the location, quality and intensity of the pain 
sensation. The quantification of pain is possible with the help of the visual analog scale (VAS) or 
the numeric rating scale (NRS). However, these methods are only plausible during situations 
where the patient is sufficiently alert and cooperative, which is not always possible in the 
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medical field, including times where the patient is in post-surgery phases or in this case a 
neonate who is not able to communicate the severity of pain (Walter et al., 2013). Overall, the 
methods are either considered inadequate or still in development. If the conditions do not allow 
for a sufficiently valid measurement of pain, treating the pain may lead to an over- or 
underestimation of analgesic administration as well as long-term effects such as alteration in 
response to subsequent painful experience. Current hospital practices require the nursing staff to 
apply validated pain scoring methods before taking appropriate actions to ameliorate newborn 
pain or discomfort. However, current nursing workload in the NICU does not allow bedside 
nurses to assess neonatal pain accurately (Hall & Anand, 2014). Additionally, if the validated 
pain scales are not working properly, the pain is under rated or over rated frequently. Many pain 
scales such as PIPP combine behavioural, physiological, and other variables, but these variables 
may not respond to neonatal pain in similar or specific ways. The inter-rater reliability and 
subjectivity of human assessments are further limiting factors in their prevalent use (Hall & 
Anand, 2014). The use of qualitative or subjective methods, rather than quantifiable data for 
neonatal pain assessment, results in inconsistencies. Due to a large pharmacokinetic variability of 
analgesic drugs in neonates, their pain management is often of poor quality and inconsistent from 
shift to shift (Guedj et al., 2014). Adopting an objective pain assessment method will greatly 
enhance the quality of pain management in NICUs by avoiding untreated pain or excessive 
analgesia. The case study provided in this thesis verifies that the PIPP scores were not 
consistently collected compared to the automated score of APIPP.  Pain assessment methods 
should be designed to reduce nursing workload and the side effects of under- or overdosing 
analgesics. Studies that aim at a practical application of findings in the field of automatic pain 
recognition, specifically within the neonatal domain, are virtually non-existent today. The results 
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reported in this thesis as well as in earlier studies indicate a high potential for developing 




















Chapter 8 - Conclusion 
In summary, identification of pain in neonates continues to challenge nurses and physicians who 
hold the responsibility to provide optimal care to this vulnerable population.  The inability to 
affectively quantify and relieve pain leaves health care providers with limited knowledge to 
guide practice. It remains a clinical art to combine patients’ reports, behavioural observation, and 
physiologic measurement with the history, physical exam, laboratory information, and overall 
clinical context in guiding clinical judgments and therapeutic interventions (Berde & McGrath, 
2009). The complexity of pain in newborns was not recognized until the 1980s. Infants were 
believed to have no capacity to experience or remember pain; as such infants were not treated for 
pain in circumstances where pain would be anticipated. Since then, assessment and management 
of pain have advanced and has become the focus of substantial research. Despite this, we are far 
from having a standardized practice for managing pain in premature infants. There are many 
variations in the methods and scales used across different healthcare organizations. Each health 
care organization uses the pain management practice that best suits their organization. It is 
important to initiate the inclusion of a wide variety of physiological indicators and contextual 
information, such as gestational age, severity of illness and severity of surgery to increase the 
sensitivity and validity of the pain scales.  This thesis outlines various studies that have displayed 
the importance and usefulness of these physiological and neurological techniques in Chapter 2. It 
is important that these findings are effectively understood and researched to create tools that can 
provide absolutely accurate detection of pain in neonates.  
The objective measurement of subjective, multidimensionality-experienced pain is still a 
key problem in the neonatal population that has yet to be adequately solved. Due to 
inconsistencies in pain measurement, opiates are being used at an increasing rate despite 
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concerns about patient safety and misuse (Midboe et al., 2011). Various automated systems have 
attempted to resolve shortcomings by using information systems to make the pain measurement 
system more reliable and time-efficient. The main goal or objective of information systems is to 
improve the performance of people in organizations through the use of information technology. 
Computer-based clinical decision support systems show promise for improving clinical decision-
making, evidence-based guideline adherence, care coordination across providers and disciplines, 
as well as patient education and communication (Midboe et al., 2011).  
Almost a decade ago, a question was asked relating to the ethical imperative to treat pain 
in infants and whether the pain management was fully effective at the time (Franck, 1997). 
Based on the findings in this thesis, as well as other similar findings of studies conducted in the 
recent past (Harrison et al., 2014; Johnston et al., 2011; Roofthooft, Simons, Anand, Tibboel, & 
van Dijk, 2014), the answer is unfortunately still “no”. As a community of clinicians, health care 
researchers, and funders of research, greater attempts should be made to ensure that a newborn 
infant does not need to undergo an unnecessary painful procedure without provision of effective 
pain reduction. This cannot be done until we have the tools to assess pain in an effective manner. 
Misreported pain is the cause of majority of the concerns reported in this thesis.  
8.1 Research and Findings 
To explore the research questions of this thesis, firstly, a literature review was completed in 
chapter 2 to present various studies conducted in the area of pain management to uncover the 
need for an automated real-time based pain scoring system in the NICU. Literature review was 
structured based on three significant themes of the thesis. Firstly, a discussion on how health 
information systems can be used to assess pain was explored. Secondly, a review was presented 
on how physiological parameters can be used for the assessment of pain. It was determined that 
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physiological cues can prove to be very effective in the assessment of pain in premature infants. 
However, their specificity as a measure of pain reactivity in premature infants has not been 
investigated in great detail. Lastly, a review was conducted on various computerized/ automated 
pain measurement systems to aid in designing one for the NICU. Upon completion of the review, 
it was determined that there is a lack of automated pain management systems that are designed 
specifically for the NICU. Hence, this provided a great scope for exploring this area of research 
and proposing the hypothesis to design a pain scoring system using big data analytic techniques 
that can provide frequent monitoring of pain. The Artemis platform is presented in detail in 
chapter 3 to outline its usability within this thesis. The study design presented in this thesis has 
demonstrated the utility of the Artemis platform for the effective detection and monitoring of 
pain within the neonatal population. It is possible to deploy an algorithm unique to this research 
within Artemis to create a pain detection system that can be automated.  
Chapter 4 presented the methodology in two phases outlining the preparation of data and 
the creation of the data model. The data model involved combining the abstractions and features 
from the data preparation phase to compute an automated partial pain score based on big data 
analytics and quantifiable scoring using HR, SpO2 and GA. Following this, the data model/ 
APIPP scale was evaluated in chapter 5 by comparing it with the PIPP scores collected manually 
by nurses. A thorough analysis was conducted for evaluation purposes to examine if the APIPP 
score produced greater, lesser or equal results as the PIPP score. One of the main findings from 
this evaluation was that PIPP score was not available almost 80% of the time when compared to 
APIPP score which was generated automatically using the Artemis platform. Hence, the 
hypothesis was proved that more frequent monitoring of pain is possible by creating an 
automated system using Artemis platform. Furthermore, when evaluating the difference between 
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two scores, a minimal difference of two and three was prominent. Such a finding is noteworthy 
as it is significant to note that PIPP scoring is scored on a 21-point scale whereas APIPP is 
scored on a 9-point scale. It can be inferred that the PIPP was perhaps highly scored on 
physiological parameters and GA due to its score being very close to the APIPP score.  This can 
be due to many reasons such as perhaps the infant’s inability to give behavioural cues for scoring 
purposes. Hence the score being highly scored on only the available physiological cues such as 
HR and SpO2. Such a negligible difference between two scales proposes further investigation.  
To create a physiologic based pain scale, it was imperative to investigate how 
physiological changes can be useful in detecting a pain response. Hence, Chapter 6 explored the 
physiological and clinical side of pain by outlining in detail the resourcefulness of HR as a 
physiological marker for detecting pain. Various statistical experiments were conducted to 
review HR in accordance with GA, surgical details and PIPP scoring. The results showed that 
HR average can prove to be a useful measure in detecting painful events as this correlated with 
the surgery each subject underwent. Subjects who underwent severe surgeries, presented with a 
high HR compared to those who did not undergo a surgery. Similarly, in pain detection, high HR 
will show abnormalities or pain that is present in an infant at a given time the score is being 
collected. In an automated pain detection system, this has the potential to give alerts to health 
care professionals when the HR goes above the set threshold for a particular subject. These 
findings also reiterate the need to design a pain assessment tool that adjusts for gestational age as 
the baseline heart rate of each subject is different at varying gestational ages. Chapter 7 presented 
a discussion which brings together the concepts presented in each chapter. 
Upon completion of the study and using the knowledge presented in this thesis, it has 
been confirmed that despite the use of the DB2 system in this study, the algorithm logic can be 
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converted to the Streams Processing Language and can be applied to the Artemis platform to 
create an automated pain detection system that can run in real-time. Analyzing continuous 
physiological data in this thesis, helped to identify areas which may have been overlooked due to 
manual collection of PIPP scores at inconsistent time points. Due to having retrospective per 
second data for each subject, more information was available to predict the changes that occurred 
within the subject’s physiology that potentially would have been missed due to manual 
interpretation at inconsistent time points. This research explores an avenue that has not been 
attempted before in this domain. Using the findings presented in this thesis, this novel research 
has the potential to make significant contributions to the medical and informatics field. 
8.2 Limitations  
Various limitations have occurred while conducting the experiments in this thesis. One of the 
first limitations of the study was that the data used was retrospective. Due to retrospective data 
collection, contemplating contextual details about the subject, such as dosage of analgesia given 
or the time it was administered, was difficult. Because of this, analyzing PIPP scores that were 
collected by nurses was also difficult. Since the population for this data set was that of surgical 
patients, many were administered analgesic medications that could prevent accurate pain scoring. 
In the future, prospective data collection is imperative, where subjects will be recruited based on 
specific eligibility criteria. An example of such criteria include those who are not using 
medications that could alter their response to pain. In this data set, most PIPP scores were less 
than 10, while a PIPP score of 2 and 3 was the most frequent. This is not a significant change as 
the PIPP score is scored out of 21. Due to a larger proportion of the study population undergoing 
surgeries and under analgesia, the recorded PIPP scores were not very high. Also, each subject 
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used in this research was unique as subjects had different surgical procedures, making it almost 
impossible to standardize for testing purposes. 
Furthermore, the PIPP scores were not collected continuously but rather collected at 
random time points. On the other hand, APIPP score data was available for every hour for each 
patient. As a result, continuous data analysis was not possible, as the availability of APIPP and 
PIPP scores did not match. As such, comparing such data was difficult as more than half the data 
could not be used for scoring analysis. The quality of the Artemis data for the timeframe chosen 
for this thesis was also poor as many hours of data were missing due to artifacts. As a result, 
some subjects had to be excluded from the study analysis and only the subjects who had 
continuous data were used.  
8.3 Future Work 
In the future, this work will be used to design a physiological indicator based scale that can be 
integrated into a decision support system named Artemis. Using various physiological data 
streams, the novel scale can be integrated into the Artemis platform to predict nociceptive events. 
With such an informatics tool, the identification of nociceptive stimuli can be improved, and 
therefore, improve the use of drugs and non-pharmacological interventions for pain relief. Such a 
pain assessment system can provide continuous and minimally biased assessment of pain. Future 
work can attempt to implement this theoretical design in streams and test the implementation in 
SPL, which is the primary language used by the Artemis platform. This avenue of research 
presents future opportunities, a few of which could include the use of full 24-hour data sets for 
all patients as well as the continuous real-time analysis of the data. Through this design of a pain 
scale, alert systems can also be designed in the CDSS to assist the nurses or other health care 
professionals. These alert systems can be based on threshold changes in the physiological 
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parameters that are detected by the system. For this, it is important to set baseline parameters for 
each neonate within the system. By doing this, the CDSS can provide alerts when it observes an 
unusual physiological change.  This work can enable, not only detection, but also quantification 
of pain in neonates as mild, moderate or severe by examining and deriving patterns within the 
physiological data streams.  
Future work should also carry out similar research in a prospective manner in order to 
reduce limitations. Following this thesis work, a prospective observational study can be 
conducted with two cohort of neonatal infants, with one group being surgical and the other being 
the non-surgical group. To validate this approach, APIPP can be run and scored for each patient 
and simultaneously, nurses can collect PIPP scores as frequently as the APIPP score is generated.  
Incorporation of contextual information with other pain indicators is essential for the 
refinement of the assessment process. This thesis has presented a need for developing a 
continuous, context-sensitive, and multimodal system, which will provide best practice to assess 
neonatal pain. The knowledge from this thesis can be used to research and implement this design 
in an NICU in the future. Furthermore, this thesis will provide a valid insight into the importance 
of the assessment of physiological parameters in the area of neonatal pain management. In turn, 
better and more accurate pain management strategies can be created, improving the health of the 
youngest members of society.  
8.4 Concluding Remarks 
The research in automated continuous detection of pain using physiological parameters has not 
been previously attempted. Most work in this domain has involved great emphasis on 
behavioural parameters for scoring pain. This thesis provides extensions in the form of research 
contributions and presents a novel concept of using automated real-time scoring of pain 
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parameters. This thesis also has presented a framework that will facilitate the implementation of 
automated pain detection system that can be executed within the Artemis platform to assess pain 
in a continuous and reliable manner. This has the potential to provide regular pain assessment in 
the NICU which can lead to better pain assessment and management that can otherwise go 
unnoticed and result in eventual reduced mortality and morbidity of patients.  
The primary objective of this thesis was to investigate how big data analytic techniques 
can be used to generate a neonatal pain score in the future. In parallel with this objective, another 
aim of this research was to assess physiological parameters in order to explore the possibility of 
generating an automated pain score using physiological elements. Overall, using retrospective 
physiological data, these objectives were fulfilled to create an alternate way to design and 
generate a score that was being generated manually. Current practice in an NICU involves the 
meticulous, time-consuming and bias process of manual interpretation of pain scores by nurses, 
subsequently the automation of this process has the potential to increase the time frequency at 
which pain scores are recorded, eliminate bias and inconsistency of scoring as well as improve 
the timing of medical intervention to allow for healthy development in neonates. Through this 
retrospective analysis of pain scoring, it was determined that this approach can be applied to a 
real-time automated environment enabled by stream computing. Applicability and future work 
relating to what has been described in this thesis will lead to innovative automated systems 
integrated into clinical practice. This design of the APIPP scoring as a clinical decision support 
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